Your selection contains 234 outcomes. Edit selection.
Filter publications
-
DOLNIKOVA, Alexandra, Dmitry KAZANTSEV, Magdalena KLANOVA, Eva POKORNA, Dana SOVILJ, Cristina Daniela KELEMEN, Liliana TUSKOVA, Eva HOFERKOVÁ, Marek MRÁZ, Karel HELMAN, Nikola CURIK, Katerina MACHOVA POLAKOVA, Ladislav ANDĚRA, Marek TRNĚNÝ and Pavel KLENER. Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status. Blood advances. AMSTERDAM: ELSEVIER, 2024, 10.1182/bl. ISSN 2473-9529.
-
HOFERKOVÁ, Eva, Václav ŠEDA, Soňa CESNÁRIKOVÁ, Jan VERNER, Tomáš LOJA, Květoslava MATULOVÁ, Hana SKUHROVÁ FRANCOVÁ, Eva ONDROUŠKOVÁ, Daniel FILIP, Nicolas BLAVET, Miroslav BOUDNÝ, Gabriela MLADONICKÁ PAVLASOVÁ, Josef VEČEŘA, Laura ONDRIŠOVÁ, Petra PAVELKOVÁ, Kryštof HLAVÁČ, Lenka KOŠŤÁLOVÁ, Androniki MICHAELOU, Šárka POSPÍŠILOVÁ, Jana DORAZILOVÁ, Václav CHOCHOLA, Josef JAROŠ, Michael DOUBEK, Marie JAROŠOVÁ, Aleš HAMPL, Lucy VOJTOVÁ, Leoš KŘEN, Jiří MAYER and Marek MRÁZ. Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug. Leukemia. LONDON: SPRINGERNATURE, 2024, vol. 38, No 8, p. 1-13. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-024-02284-w.
-
BUŠA, Daniel, Martin ČULEN, Tomáš LOJA, Ivana JEŽÍŠKOVÁ, Alois FOLTA and Jiří MAYER. Acute myeloid leukemia suppression by palbociclib and ponatinib in patient-derived xenograft. In 23. Pražské hematologické dny, Praha. 2023.
-
ČULEN, Martin, Tomáš LOJA, Daniel BUŠA, Zdeňka HERUDKOVÁ, Jan HÝL, Jakub VLAŽNÝ, K. LIŠKOVÁ, Martin REPKO, Lucy VOJTOVÁ and Jiří MAYER. Biomaterial selection does not affect AML engraftment in humanized ossicles. (Biomaterial selection does not affect AML engraftment in humanized ossicles - conference abstract.). In 12th International Conference Analytical Cytometry, Praha. 2023.
-
ČESKÁ, Katarína, Jan PAPEŽ, Hana OŠLEJŠKOVÁ, Ondřej SLABÝ, Lenka RADOVÁ, Tomáš LOJA, Zuzana LIBÁ, Anna SVĚRÁKOVÁ, Milan BRÁZDIL and Štefánia AULICKÁ. CCL2/MCP-1, interleukin-8, and fractalkine/CXC3CL1: Potential biomarkers of epileptogenesis and pharmacoresistance in childhood epilepsy. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY. OXON: ELSEVIER, 2023, vol. 46, September 2023, p. 48-54. ISSN 1090-3798. Available from: https://dx.doi.org/10.1016/j.ejpn.2023.06.001.
-
HOFERKOVÁ, Eva, Soňa KADÁKOVÁ, Václav ŠEDA, Jan VERNER, Miroslav BOUDNÝ, Gabriela MLADONICKÁ PAVLASOVÁ, Tomáš LOJA, Daniel FILIP, Josef VEČEŘA, Květoslava MATULOVÁ, Hana SKUHROVÁ FRANCOVÁ, Sonali SHARMA, Laura ONDRIŠOVÁ, Veronika PALUŠOVÁ, Lucy VOJTOVÁ, Leoš KŘEN, Michael DOUBEK and Marek MRÁZ. Coculture model with CD40L, IL4 and IL21 for study chronic lymphocytic leukemia proliferation. In CEITEC PhD Conference 2023, Brno. 2023.
-
ONDRIŠOVÁ, Laura, Václav ŠEDA, Giorgia CHIODIN, Kryštof HLAVÁČ, Lenka KOŠŤÁLOVÁ, Daniel FILIP, Pedro FARIA ZENI, Anna PANOVSKÁ, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, Martin ŠIMKOVIČ, Filip VRBACKÝ, Daniel LYSÁK, Stacey M. FERNANDEZ, MS. DAVIDS, Alba MAIQUES-DIAZ, Stella CHARALAMPOPOULOU, Jose I. MARTIN-SUBERO, Jennifer R. BROWN, Michael DOUBEK, Francesco FORCONI, Jiří MAYER and Marek MRÁZ. FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy. In EHA 2023 in HemaSphere (2023). 2023. ISSN 2572-9241.
-
HLAVÁČ, Kryštof, Laura ONDRIŠOVÁ, Václav ŠEDA, Eva HOFERKOVÁ, G. CHIODIN, Lenka KOŠŤÁLOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel FILIP, Pedro FARIA ZENI, Jan OPPELT, Anna PANOVSKÁ, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, M. ŠIMKOVIČ, F. VRBACKÝ, Daniel LYSÁK, SM. FERNANDES, MS. DAVIDS, A. MAIQUES-DIAZ, S. CHARALAMPOPOULOU, I. MARTIN-SUBERO, JR. BROWN, Michael DOUBEK, Francesco FORCONI, Jiří MAYER and Marek MRÁZ. Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia. In Czech Annual Cancer Research Meeting, Olomouc. 2023.
-
ONDRIŠOVÁ, Laura, Václav ŠEDA, Eva HOFERKOVÁ, G. CHIODIN, Kryštof HLAVÁČ, Lenka KOŠŤÁLOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel FILIP, Pedro FARIA ZENI, Jan OPPELT, Anna PANOVSKÁ, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, M. SIMKOVIC, F. VRBACKÝ, Daniel LYSÁK, SM. FERNANDES, MS. DAVIDS, A. MAIQUES-DIAZ, S. CHARALAMPOPOULOU, JI. MARTIN-SUBERO, JR. BROWN, Michael DOUBEK, F. FORCONI, Jiří MAYER and Marek MRÁZ. FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy. In ICML, Švýcarsko, Lugano. 2023.
-
KONEČNÁ, Kateřina, Lukáš TICHÝ, Tomáš LOJA, Tereza PŘEROVSKÁ and Lenka FAJKUSOVÁ. Functional analysis of LDLR variants using flow cytometry. In ASHG Annual Meeting 2023. 2023.
-
KONEČNÁ, Kateřina, Lukáš TICHÝ, Tomáš LOJA, Tereza PŘEROVSKÁ and Lenka FAJKUSOVÁ. Functional analysis of LDLR variants using flow cytometry and western blot. In XXII. setkání biochemiků a molekulárních biologů. 2023.
-
DOSTÁLOVÁ, Lenka, Aneta LEDEREROVÁ, Helena PESCHELOVÁ, Tomáš LOJA and Michal ŠMÍDA. Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation. In CRISPR as a research tool in cancer and regenerative medicine, Stockholm, Švédsko. 2023.
-
DOSTÁLOVÁ, Lenka, Aneta LEDEREROVÁ, Helena PESCHELOVÁ, Tomáš LOJA and Michal ŠMÍDA. Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation in rituximab-resistant cells. In PhD and PostDoc RETREAT, Sněžné, Milovy. 2023.
-
NAVRÁTILOVÁ, Polina, Jan EMMER, Tomáš LOJA and Monika PÁVKOVÁ GOLDBERGOVÁ. Characterisation of Macrophage Response to Nickel Nanoparticles and Ions Released from Biomaterials. In MATEDAS 2023, 17th INTERNATIONAL CONFERENCE ON MATERIALS AND TECHNOLOGIES FOR DEFENSE AND SECURITY. 2023.
-
DOSTÁLOVÁ, Lenka, Aneta LEDEREROVÁ, Helena PESCHELOVÁ, Tomáš LOJA and Michal ŠMÍDA. Identification of novel targets that upregulate CD20 expression in rituximab-resistant cells with the use of genomewide CRISPR screening. In XX. International Workshop on CLL (iwCLL 2023), Boston, USA. 2023.
-
BUŠA, Daniel, Martin ČULEN, Tomáš LOJA, Ivana JEŽÍŠKOVÁ, Adam FOLTA and Jiří MAYER. Inhibition of acute myeloid leukemia using palbociclib and ponatinib in a patient-derived xenograft model. In Actual Problems of Medical Prevention, Baku, Azerbajdžán. 2023.
-
MRÁZ, Marek, Václav ŠEDA and Laura ONDRIŠOVÁ. Inhibitors for treatment of hematological malignancies. 2023.
-
ŠEDA, Václav and Marek MRÁZ. Mechanismy adaptace CLL buněk na léčbu BCR inhibitory. In 15. Plenární zasedání české skupiny pro chronickou lymfocytární leukémii, Praha. 2023.
-
FEDOROVÁ, Veronika, Kateřina AMRUZ ČERNÁ, Jan OPPELT, Veronika POSPÍŠILOVÁ, Tomáš BÁRTA, Marek MRÁZ and Dáša BOHAČIAKOVÁ. MicroRNA Profiling of Self-Renewing Human Neural Stem Cells Reveals Novel Sets of Differentially Expressed microRNAs During Neural Differentiation In Vitro. Stem Cell Reviews and Reports. NEW YORK: SPRINGER, 2023, vol. 19, No 5, p. 1524-1539. ISSN 2629-3269. Available from: https://dx.doi.org/10.1007/s12015-023-10524-2.
-
HLAVÁČ, Kryštof, Laura ONDRIŠOVÁ, Václav ŠEDA, Petra PAVELKOVÁ, Eva HOFERKOVÁ, Daniel FILIP and Marek MRÁZ. Molecular response of chronic lymphocytic leukemia cells to targeted therapy. In XXII. Interdisciplinary Meeting of Young Life Scientists, Milovy. 2023.
-
FARIA ZENI, Pedro, Daniel FILIP, Miroslav BOUDNÝ, Michaela MEDKOVÁ, Libuše JANSKÁ, Androniki MICHAELOU, Laura ONDRIŠOVÁ, Eva HOFERKOVÁ, Josef VEČEŘA, Kryštof HLAVÁČ, Lenka KOŠŤÁLOVÁ, Petra PAVELKOVÁ, Erika BAJUSOVÁ, Péter KACZ, Šárka POSPÍŠILOVÁ, Michael DOUBEK, Jiří MAYER, Václav ŠEDA and Marek MRÁZ. Nekódující RNA v biologii maligních B lymfocytů. (Non-coding RNAs in the biology of malignant B lymphocytes.). In XXVI. Biologické dny, Brno. 2023.
-
KACZ, Péter and Marek MRÁZ. On the role of long non-coding RNA in BCR signaling regulation in chronic lymphocytic leukemia. In PhD and PostDoc RETREAT, Sněžné, Milovy. 2023.
-
MIKULOVÁ, Antónia, Pavlína JANOVSKÁ, Jan VERNER, Hana PLEŠINGEROVÁ, Olga VONDÁLOVÁ BLANÁŘOVÁ, Pavlína KEBKOVÁ, Kateřina SOTOLÁŘOVÁ, Jana BARTOŠÍKOVÁ, M. CHORVÁTOVÁ, Terézia KURUCOVÁ, Tomáš LOJA, Boris TICHÝ, Lukáš KUBALA and Vítězslav BRYJA. The role of casein kinase 1 inhibition in treatment of chronic lymphocytic leukemia. In 12th International Conference Analytical Cytometry, Praha. 2023.
-
FARIA ZENI, Pedro, Michaela MEDKOVÁ, K. TRACHTOVÁ, L. JANSKÁ, Václav ŠEDA, Eva HOFERKOVÁ, Nandan Mysore VARADARAJAN, Sonali SHARMA, Aleš OBRDLÍK, Štěpánka VAŇÁČOVÁ, A. MAIQUES-DIAZ, JI. MARTÍN-SUBERO and Marek MRÁZ. The role of long non-coding RNAs in BCR-mediated CLL activation. In CEITEC PhD Conference, Brno. 2023.
-
MEDKOVÁ, Michaela, Pedro FARIA ZENI, L. JANSKÁ, Sonali SHARMA, Androniki MICHAELOU, Václav ŠEDA, Lenka KOŠŤÁLOVÁ, Laura ONDRIŠOVÁ, V. PALUŠOVÁ, Eva VOJÁČKOVÁ, Daniel FILIP, Josef VEČEŘA, Miroslav BOUDNÝ, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. The role of long non-coding RNAs in the microenvironmental interactions of malignant B cells. In CEITEC PhD conference, Brno. 2023.
-
MEDKOVÁ, Michaela, Pedro FARIA ZENI, L. JANSKÁ, Péter KACZ, Sonali SHARMA, Androniki MICHAELOU, Václav ŠEDA, Lenka KOŠŤÁLOVÁ, Laura ONDRIŠOVÁ, Veronika PALUŠOVÁ, Eva VOJÁČKOVÁ, Daniel FILIP, Josef VEČEŘA, Miroslav BOUDNÝ and Marek MRÁZ. The role of long non-coding RNAs in the microenvironmental interactions of malignant B cells. In PhD and PostDoc RETREAT, Sněžné, Milovy. 2023.
-
MRÁZ, Marek, Laura ONDRIŠOVÁ, Václav ŠEDA, Eva HOFERKOVÁ, G. CHIODIN, Kryštof HLAVÁČ, Lenka KOŠŤÁLOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel FILIP, Pedro ZENI, Jan OPPELT, Anna PANOVSKÁ, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, M. ŠIMKOVIČ, F. VRBACKÝ, Daniel LYSÁK, SM. FERNANDES, A. DAVIDS, A. MAIQUES-DIAZ, S. CHARALAMPOPOULOU, J. MARTIN-SUBERO, J. BROWN, Michael DOUBEK, F. FORCONI and Jiří MAYER. Transcription factor FoxO1 Mediates Adaptive Increase in Akt Activity and Cell Survival During BCR Inhibitor Therapy in CLL. In XX. International Workshop on CLL (iwCLL 2023), Boston, USA. 2023.
-
KLEDUS, Filip, Daniel FILIP and Marek MRÁZ. Transformace indolentního folikulární lymfomu v difuzní velkobuněčný B-lymfom – molekulární podstata „nádorové agresivity“ (Transformation of indolent follicular lymphoma into diffuse large B-cell lymphoma – the molecular basis of “cancer aggressiveness”). Klinická onkologie. Praha: Česká lékařská společnost J. E. Purkyně, 2023, vol. 36, No 4, p. 353-363. ISSN 0862-495X. Available from: https://dx.doi.org/10.48095/ccko2023353.
-
ONDRIŠOVÁ, Laura, Václav ŠEDA, Eva HOFERKOVÁ, Lenka KOŠŤÁLOVÁ, Kryštof HLAVÁČ, Petra PAVELKOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Pedro FARIA ZENI, Karla PLEVOVÁ, Daniel FILIP, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. Transkripční faktor FoxO1 v adaptaci chronické lymfocytární leukémie na cílenou léčbu. (Transcription factor FoxO1 in adaptation of chronic lymphocytic leukemia to targeted therapy.). In XXVI. Biologické dny, Brno. 2023.
-
MRÁZ, Marek, Ján DEVÁN and Kateřina MUSILOVÁ. Způsob stanovení prognózy u pacientů s folikulárním lymfomem (Method of prognosis in patients with follicular lymphoma). 2023.
-
MRÁZ, Marek. 5′-UTR mRNA splicing determines CD20 levels. Blood. Washington DC, USA: American Society of Hematology, 2023, vol. 142, No 20, p. 1676-1678. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2023022305.
-
ONDRIŠOVÁ, Laura, Václav ŠEDA, Eva HOFERKOVÁ, Lenka KOŠŤÁLOVÁ, Kryštof HLAVÁČ, Gabriela MLADONICKÁ PAVLASOVÁ, Jan OPPELT, Pedro FARIA ZENI, Daniel FILIP, Michael DOUBEK, Kateřina AMRUZ ČERNÁ, Jiří MAYER and Marek MRÁZ. Adaptace buněk chronické lymfocytární leukémie na cílenou léčbu BCR inhibitory. In XXV. Biologické dny, Brno. 2022.
-
MRÁZ, Marek and Daniel FILIP. Diagnostická sada pro stanoveni prognózy folikulárního lymfomu s pomocí kvantifikace miRNA (A diagnostic kit for prognostication of follicular lymphoma using miRNA quantification). 2022.
-
ONDROUŠKOVÁ, Eva, Michaela BOHÚNOVÁ, Kristýna ZÁVACKÁ, Patrik ČECH, Petra ŠMUHAŘOVÁ, Miroslav BOUDNÝ, Martina ORŠULOVÁ, Anna PANOVSKÁ, Lenka RADOVÁ, Michael DOUBEK, Karla PLEVOVÁ and Marie JAROŠOVÁ. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations. Frontiers in Oncology. Lausanne: Frontiers Media S.A., 2022, vol. 12, June 2022, p. 1-11. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2022.859618.
-
ŠEDA, Václav, Eva VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Tomáš LOJA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, S. ZHANG, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. GAB1 as novel therapeutic target in B lymphoid and myeloid malignancies. In XXXIV. Olomoucké hematologické dny in Transfuze a hematologie dnes. 2022.
-
MRÁZ, Marek. Genetic mechanism for the loss of PRAME in B cell lymphomas. Journal of Clinical Investigation. Ann Arbor: AMER SOC CLINICAL INVESTIGATION INC, 2022, vol. 132, No 14, p. nestrankovano, 1 pp. ISSN 0021-9738. Available from: https://dx.doi.org/10.1172/JCI160983.
-
CHIODIN, Giorgia, Samantha DRENNAN, Enrica A MARTINO, Laura ONDRIŠOVÁ, Isla HENDERSON, del Rio LUIS, Ian TRACY, Annalisa D'AVOLA, Helen PARKER, Silvia BONFIGLIO, Lydia SCARF, Lesley-Ann SUTTON, Jonathan C STREFFORD, Jade FORSTER, Oliver BRAKE, Kathleen N POTTER, Benjamin SALE, Stuart LANHAM, Marek MRÁZ, Paolo GHIA, Freda K STEVENSON and Francesco FORCONI. High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL. BLOOD ADVANCES. WASHINGTON: AMER SOC HEMATOLOGY, 2022, vol. 6, No 18, p. 5494-5504. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2021006659.
-
ŠANDOVÁ, Veronika, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Veronika PALUŠOVÁ, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ, Anna PANOVSKÁ, Michael DOUBEK, M. DAVIDS, J. BROWN, Jiří MAYER and Marek MRÁZ. IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib. In 22. Pražské hematologické dny Hematologie, Praha. 2022.
-
HOFERKOVÁ, Eva, Soňa KADÁKOVÁ and Marek MRÁZ. In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing. CANCERS. SWITZERLAND: MDPI, 2022, vol. 14, No 13, p. 3087-3107. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers14133087.
-
KADÁKOVÁ, Soňa, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Daniel FILIP, Josef VEČEŘA, Lenka KOŠŤÁLOVÁ, Miroslav BOUDNÝ, Michaela MEDKOVÁ, Pedro FARIA ZENI, Veronika PALUŠOVÁ, Jiří MAYER, Václav ŠEDA and Marek MRÁZ. Modelling chronic lymphocytic leukaemia microenvironment. In The Biomania Student Scientific Meeting, Brno. 2022.
-
MĄDRZYK, Marie, Táňa MACHÁČKOVÁ, Karolína TRACHTOVÁ, Tina Catela IVKOVIĆ, Kamila SOUČKOVÁ, Jan KOTOUČEK, Josef MAŠEK, Tomáš LOJA, Milana ŠACHLOVÁ and Ondřej SLABÝ. Sekvenování dlouhých nekódujících RNA v exozomech u pacientů s kolorektálním karcinomem (Sequencing of long non-coding RNAs in exosomes of colorectal cancer patients). Klinická onkologie. Praha: Česká lékařská společnost J. E. Purkyně, 2022, vol. 35, Supplementum 1, p. "S138"-"S141", 3 pp. ISSN 0862-495X. Available from: https://dx.doi.org/10.48095/ccko20221S107.
-
KHIRSARIYA, PrashantKumar, Patrik POSPÍŠIL, Lukáš MAIER, Miroslav BOUDNÝ, Martin BABÁŠ, Ondřej KROUTIL, Marek MRÁZ, Robert VÁCHA and Kamil PARUCH. Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides. Journal of Medicinal Chemistry. Washington: American Chemical Society, 2022, vol. 65, No 7, p. 5701-5723. ISSN 0022-2623. Available from: https://dx.doi.org/10.1021/acs.jmedchem.1c02228.
-
FARIA ZENI, Pedro, Michaela MEDKOVÁ, Karolína TRACHTOVÁ, L. JÁNSKÁ, Václav ŠEDA, Sonali SHARMA, Josef VEČEŘA, Laura ONDRIŠOVÁ, Miroslav BOUDNÝ, Veronika PALUŠOVÁ, Veronika ŠANDOVÁ, Daniel FILIP, Lenka KOŠŤÁLOVÁ and Marek MRÁZ. The role of long non-coding RNAs in BCR-mediated CLL activation. In CEITEC PhD Conference, Brno. 2022.
-
MEDKOVÁ, Michaela, Pedro FARIA ZENI, Karolína TRACHTOVÁ, Sonali SHARMA, Václav ŠEDA, Lenka KOŠŤÁLOVÁ, Laura ONDRIŠOVÁ, Veronika PALUŠOVÁ, Eva HOFERKOVÁ, Daniel FILIP, Josef VEČEŘA, Miroslav BOUDNÝ, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. The role of long non-coding RNAs in the microenvironmental interactions of malignant B cells. In CEITEC PhD Conference, Brno. 2022.
-
KADÁKOVÁ, Soňa, Tereza VÁŇOVÁ, Jiří SEDMÍK, Petr FOJTÍK and Dáša BOHAČIAKOVÁ. Using a human pluripotent stem cell-based model to study the Alzheimer's disease pathogenesis in vitro. In Meeting of Biochemists and Molecular Biologists, Brno. 2022.
-
HOFERKOVÁ, Eva, Soňa KADÁKOVÁ, Václav ŠEDA, Tomáš LOJA, Gabriela MLADONICKÁ PAVLASOVÁ, Jan VERNER, Václav CHOCHOLA, Josef JAROŠ, Květoslava LIŠKOVÁ, Daniel FILIP, Josef VEČEŘA, Pedro FARIA ZENI, Jana DORAZILOVÁ, Eva ONDROUŠKOVÁ, Laura ONDRIŠOVÁ, Miroslav BOUDNÝ, Leoš KŘEN, Lucy VOJTOVÁ, Jiří MAYER and Marek MRÁZ. Versatile coculture systém to study chronic lymhocytic leukemia proliferation. In CEITEC PhD Conference, Brno. 2022.
-
ONDROUŠKOVÁ, Eva, Michaela BOHÚNOVÁ, Kristýna ZÁVACKÁ, P. ČECH, Petra ŠMUHAŘOVÁ, Karla PLEVOVÁ, Miroslav BOUDNÝ, Anna PANOVSKÁ, Lenka RADOVÁ, Michael DOUBEK and Marie JAROŠOVÁ. Duplikace 8q24 v chronické lymfocytární leukémii: Cytogentická a molekulárně-biologická analýza aberací genu MYC. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
-
ŠEDA, Václav, Eva VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel ZICHA, Marie KUDLIČKOVÁ PEŠKOVÁ, Jan KŘIVÁNEK, Květoslava MATULOVÁ, Leoš KŘEN, V. BENES, Markéta LITZMANOVÁ, Marek BORSKÝ, Jan OPPELT, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Z. TAN, S.X. ZHANG, Michael DOUBEK, Kateřina AMRUZ ČERNÁ, Jiří MAYER and Marek MRÁZ. FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia. Blood. Washington DC, USA: American Society of Hematology, 2021, vol. 138, No 9, p. 758-772. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020008101.
-
ŠEDA, Václav, E. VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Zhuowen TAN, Shelley ZHANG, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. FoxO1-GAB1 Axis Regulates Homing Capacity and Tonic AKT Activity in Chronic Lymphocytic Leukemia: Novel Therapeutic Target. In 26th Congress of the European Hematology Association, červen 2021 in HemaSphere. 2021.
-
ŠEDA, Václav, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors. In XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL). 2021.
-
MRÁZ, Marek, Václav ŠEDA, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Jiří MAYER. GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target. In XXVI. CSBMB 2021. 2021.
-
ŠEDA, Václav, Eva VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, D. ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Zhuowen TAN, Shelley ZHANG, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. GAB1 reguluje tonickou AKT signalizaci a migraci buněk chronické lymfatické leukémie: implikace pro kombinační léčbu s BCR inhibitory. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
-
SHARMA, Sonali, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Kateřina AMRUZ ČERNÁ, Eva HOFERKOVÁ, Daniel FILIP, Laura ONDRIŠOVÁ, Veronika ŠANDOVÁ, Lenka KOŠŤÁLOVÁ, Pedro FARIA ZENI, Marek BORSKÝ, Jan OPPELT, K. LISKOVA, Leoš KŘEN, Andrea JANÍKOVÁ, Šárka POSPÍŠILOVÁ, S. FERNANDES, M. SHEHATA, L. RASSENTI, U. JAEGER, Michael DOUBEK, M. DAVIDS, J. BROWN, Jiří MAYER, T. KIPPS and Marek MRÁZ. Ibrutinib Blocks CD40 Signalling in CLL in Vivo by Reducing TRAF4 Levels. In XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL). 2021.
-
MRÁZ, Marek. Ibrutinib blocks CD40 signalling in malignant B cells by reducing TRAF4 levels. In ESH Translational Research E-Conference. 2021.
-
ŠANDOVÁ, Veronika, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Kateřina AMRUZ ČERNÁ, Sonali SHARMA, Veronika PALUŠOVÁ, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ, S.M. FERNANDES, Anna PANOVSKÁ, Michael DOUBEK, M.S. DAVIDS, J.R. BROWN, Jiří MAYER and Marek MRÁZ. IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K delta inhibitor idelalisib. haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2021, vol. 106, No 11, p. 2995-2999. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2021.278644.
-
ŠANDOVÁ, Veronika, Marek MRÁZ, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Veronika PALUŠOVÁ, Yvona BRYCHTOVÁ, S. FERNANDES, Michael DOUBEK, M. DAVIDS and J. BROWN. IL4-STAT6 Signaling Induces CD20 in Chronic Lymphocytic Leukemia and This Axis Is Repressed by PI3Kδ Inhibitor Idelalisib. In XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL). 2021.
-
ZENI, Pedro and Marek MRÁZ. LncRNAs in adaptive immunity: role in physiological and pathological conditions. RNA Biology. Philadelphia: Taylor & Francis Inc, 2021, vol. 18, No 5, p. 619-632. ISSN 1547-6286. Available from: https://dx.doi.org/10.1080/15476286.2020.1838783.
-
MRÁZ, Marek. Microenvironmental interactions in B cell leukemias and lymphomas: Implications for targeted therapy. In 14th IMG PhD Conference, Praha. 2021.
-
MRÁZ, Marek. MicroRNAs in the regulation of microenvironmental interactions of malignant B cells. In EpiMeeting. 2021.
-
SHARMA, Sonali, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Kateřina AMRUZ ČERNÁ, E. VOJÁČKOVÁ, Daniel FILIP, Laura ONDRIŠOVÁ, Veronika ŠANDOVÁ, Lenka KOŠŤÁLOVÁ, Pedro FARIA ZENI, Michaela MEDKOVÁ, M. ZELINKOVÁ, Josef VEČEŘA, Miroslav BOUDNÝ, Jan OPPELT, K. LISKOVA, Leoš KŘEN, Andrea JANÍKOVÁ, Šárka POSPÍŠILOVÁ, SM. FERNANDES, M SHEHATA, LZ. RASSENTI, U. JAEGER, Michael DOUBEK, MS. DAVIDS, JR. BROWN, Jiří MAYER, TJ. KIPPS and Marek MRÁZ. miR-29 influences CD40 signaling in chronic lymphocytic leukemia (CLL): and axis affected by BCR inhibitors. In 21. Pražské hematologické dny a Post-ASH. 2021.
-
SHARMA, Sonali, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, E. VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Veronika ŠANDOVÁ, Pedro FARIA ZENI, Daniel FILIP, Lenka KOŠŤÁLOVÁ and Marek MRÁZ. miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR. In Ceitec PhD Conference. 2021.
-
SHARMA, Sonali, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Kateřina AMRUZ ČERNÁ, Eva VOJÁČKOVÁ, Daniel FILIP, Laura ONDRIŠOVÁ, Veronika ŠANDOVÁ, Lenka KOŠŤÁLOVÁ, Pedro FARIA ZENI, Marek BORSKÝ, Jan OPPELT, Květoslava LIŠKOVÁ, Leoš KŘEN, Andrea JANÍKOVÁ, Šárka POSPÍŠILOVÁ, Stacey M. FERNANDES, Medhat SHEHATA, Laura Z. RASSENTI, Ulrich JAEGER, Michael DOUBEK, Matthew S. DAVIDS, Jennifer R. BROWN, Jiří MAYER, Thomas J. KIPPS and Marek MRÁZ. miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors. Blood. Washington, DC: American Society of Hematology, 2021, vol. 137, No 18, p. 2481-2494. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020005627.
-
SHARMA, Sonali, Václav ŠEDA, E. VOJÁČKOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel FILIP, Laura ONDRIŠOVÁ, Veronika ŠANDOVÁ, Lenka KOŠŤÁLOVÁ, Pedro FARIA ZENI, Marek BORSKÝ, Šárka POSPÍŠILOVÁ, M. SHEHATA, L. RASSENTI, U. JAEGER, M DOUBEK, M. DAVIDS, J. BROWN, Jiří MAYER, T. KIPPS and Marek MRÁZ. miR-29-TRAF4 axis is a novel regulator of CD40 signaling in malignant B cells. In AACR Annual Meeting. 2021.
-
FEDOROVÁ, Veronika, Kateřina AMRUZ ČERNÁ, Veronika POSPÍŠILOVÁ, Jan RAŠKA, Tomáš BÁRTA, Marek MRÁZ and Dáša BOHAČIAKOVÁ. Název: The role of microRNA and protein-coding genes in the biology of neural stem cells. In Czech Neuroscience Society Meeting, Prague, 24.-25.11.2021. 2021.
-
VOJÁČKOVÁ, E., Jan VERNER, K. LIŠKOVÁ, Václav ŠEDA, Tomáš LOJA, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel FILIP, Sonali SHARMA, Jana DORAZILOVÁ, Hana SKUHROVÁ FRANCOVÁ, Josef VEČEŘA, Laura ONDRIŠOVÁ, Veronika ŠANDOVÁ, Pedro FARIA ZENI, Lenka KOŠŤÁLOVÁ, Miroslav BOUDNÝ, Michaela MEDKOVÁ, Lucy VOJTOVÁ, Leoš KŘEN, Jiří MAYER and Marek MRÁZ. Patient-derived Xenograft Model of Chronic Lymphocytic Leukaemia Based on Mimicking Its Microenvironment. In Ceitec PhD Conference. 2021.
-
MRÁZ, Marek. Patogeneze CLL a vztah k cílené léčbě. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
-
ŠANDOVÁ, Veronika, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Sonali SHARMA, Veronika PALUŠOVÁ, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ, SM. FERNANDES, Anna PANOVSKÁ, Michael DOUBEK, MS. DAVIDS, JR. BROWN, Jiří MAYER and Marek MRÁZ. PI3KD inhibitor idelalisib snižuje hladiny CD20 u chronické lymfocytární leukémie inhibicí IL4-STAT6 signální dráhy. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
-
BORSKÝ, Marek, Viera HRABČÁKOVÁ, Jitka NOVOTNÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Petr MULLER, Jiří MAYER, Martin TRBUŠEK and Marek MRÁZ. Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion. Leukemia Research. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2021, vol. 111, December 2021, p. 1-11. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2021.106684.
-
CERMAK, Vladimir, Aneta SKARKOVA, Ladislav MERTA, Veronika KOLOMAZNIKOVA, Veronika PALUŠOVÁ, Stjepan ULDRIJAN, Daniel ROSEL and Jan BRABEK. RNA-seq Characterization of Melanoma Phenotype Switch in 3D Collagen after p38 MAPK Inhibitor Treatment. Biomolecules. BASEL: MDPI, 2021, vol. 11, No 3, p. 1-13. ISSN 2218-273X. Available from: https://dx.doi.org/10.3390/biom11030449.
-
LOBELLO, Cosimo, Boris TICHÝ, Vojtěch BYSTRÝ, Lenka RADOVÁ, Daniel FILIP, Marek MRÁZ, I.A. MONTES-MOJARRO, N. PROKOPH, H. LAROSE, H.C. LIANG, G.G. SHARMA, L. MOLOGNI, D. BELADA, K. KAMARADOVA, F. FEND, C. GAMBACORTI-PASSERINI, O. MERKEL, Suzanne Dawn TURNER, Andrea JANÍKOVÁ and Šárka POSPÍŠILOVÁ. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia. London: Nature Publishing Group, 2021, vol. 35, No 5, p. 1500-1505. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-020-01093-1.
-
FILIP, Daniel, Sonali SHARMA, Kateřina MUSILOVÁ, Kateřina AMRUZ ČERNÁ, Lenka KOŠŤÁLOVÁ, Václav ŠEDA, Laura ONDRIŠOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Miroslav BOUDNÝ, Josef VEČEŘA, E. VOJÁČKOVÁ, Michaela MEDKOVÁ, Veronika ŠANDOVÁ and Marek MRÁZ. The biology of miRNAs in B cell malignancies and their use as biomarkers. In Precision Diagnostics Europe. 2021.
-
FARIA ZENI, Pedro, Michaela MEDKOVÁ, Karolína TRACHTOVÁ, Václav ŠEDA, Sonali SHARMA, Josef VEČEŘA, Laura ONDRIŠOVÁ, Miroslav BOUDNÝ, Veronika PALUŠOVÁ, Veronika ŠANDOVÁ, Daniel FILIP, Lenka KOŠŤÁLOVÁ and Marek MRÁZ. The role of long non-coding RNAs in the BCR-mediated activation of malignant B cells. In Ceitec PhD Conference. 2021.
-
LOBELLO, Cosimo, Boris TICHÝ, Vojtěch BYSTRÝ, Lenka RADOVÁ, Daniel FILIP, Marek MRÁZ, IA. MONTES-MOJARO, Andrea JANÍKOVÁ and Šárka POSPÍŠILOVÁ. Analysis mutational landscape in systemic anaplastic large cell lymphoma identifies novel prognostic markers. In 20. Pražské hematologické dny (Hematologie 2020), Praha. 2020.
-
BOUDNÝ, Miroslav and Martin TRBUŠEK. ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias. CANCER TREATMENT REVIEWS. OXFORD: ELSEVIER SCI LTD, 2020, vol. 88, AUG, p. 102026-102037. ISSN 0305-7372. Available from: https://dx.doi.org/10.1016/j.ctrv.2020.102026.
-
VOJÁČKOVÁ, Eva, Jan VERNER, Květoslava LIŠKOVÁ, Jana DORAZILOVÁ, Hana SKUHROVÁ FRANCOVÁ, Tomáš LOJA, Václav ŠEDA, Veronika ŠANDOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Sonali SHARMA, Pedro FARIA ZENI, Daniel FILIP, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Lucy VOJTOVÁ, Leoš KŘEN and Marek MRÁZ. Development of novel patient-derived xenograft model of chronic lymphocytic leukemia. In CEITEC PhD Conference, Brno, únor 2020. 2020.
-
ONDRIŠOVÁ, Laura and Marek MRÁZ. Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. Frontiers in Oncology. Lausanne: Frontiers Media S.A., 2020, vol. 10, OCT, p. 591577-591592. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2020.591577.
-
VEČEŘA, Josef, Jiřina PROCHÁZKOVÁ, Veronika ŠUMBEROVÁ, Veronika PÁNSKÁ, Hana PACULOVÁ, Martina KOHUTKOVÁ LÁNOVÁ, Jan MAŠEK, Dáša BOHAČIAKOVÁ, Emma Rachel ANDERSSON and Jiří PACHERNÍK. Hypoxia/Hif1 Alpha prevents premature neuronal differentiation of neural stem cells through the activation of Hes1. Stem Cell Research. Amsterdam: Elsevier, 2020, vol. 45, May 2020, p. 1-11. ISSN 1873-5061. Available from: https://dx.doi.org/10.1016/j.scr.2020.101770.
-
MRÁZ, Marek. Laboratorní analýza odpovědí na cílenou léčbu u CLL: jen vědecká obsese nebo cesta k průlomové léčbě? In Novinky v hematologii. 2020.
-
SHARMA, Sonali, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Kateřina AMRUZ ČERNÁ, Eva VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Veronika ŠANDOVÁ, Pedro FARIA ZENI, Lenka KOŠŤÁLOVÁ, Šárka POSPÍŠILOVÁ, SM. FERNANDES, M. SHEHATA, U. JÄGER, Michael DOUBEK, MS. DAVIDS, JR. BROWN, Jiří MAYER, TJ. KIPPS and Marek MRÁZ. mir-29 influences CD40 signaling in chronic lymphocytic leukemia (CLL). In 25th Congress of European Hematology Association, Amsterdam, Nizozemsko, in HemaSphere. 2020.
-
SHARMA, Sonali, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Eva VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Veronika ŠANDOVÁ, Pedro FARIA ZENI, Daniel FILIP, Lenka KOŠŤÁLOVÁ and Marek MRÁZ. mir-29 regulates the CD40 signaling in the microenvironment of chronic lymphocytic leukemia. In CEITEC PhD Conference, Brno, 2020. 2020.
-
LOBELLO, Cosimo, Vojtěch BYSTRÝ, Lenka RADOVÁ, Daniel FILIP, Marek MRÁZ, IA. MONTES-MOJARRO, N. PROKOPH, H. LAROSE, HCh. LIANG, G. SHARMA, L. MOLOGNI, D. BELADA, K. KAMARÁDOVÁ, F. FEND, C. GAMBACORTI-PASSERINI, O. MERKEL, S. TURNER, Andrea JANÍKOVÁ and Šárka POSPÍŠILOVÁ. Mutational landscape analysis in systematic anaplastic large cell lymphoma identifies novel prognostic markers. In CEITEC PhD Conference, Brno, 2020. 2020.
-
MRÁZ, Marek. Pokroky v pochopení patogeneze FL a jejich implikace pro léčbu. In Kooperativní lymfomová skupina. Praha. 2020.
-
KOŠŤÁLOVÁ, Lenka, Václav ŠEDA, Laura ONDRIŠOVÁ, Eva VOJÁČKOVÁ, Daniel FILIP, Veronika ŠANDOVÁ, Sonali SHARMA and Marek MRÁZ. Regulation of BCR signaling during therapy in chronic lymphocytic leukemia. In XIX. Interdisciplinary Meeting of Young Biologists, Biochemists and Chemists. Milovy. 2020.
-
BOUDNÝ, Miroslav and Martin TRBUŠEK. The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology. Klinická onkologie. Praha: Ambit Media a.s., 2020, vol. 33, No 1, p. 32-38. ISSN 0862-495X. Available from: https://dx.doi.org/10.14735/amko202032.
-
MLADONICKÁ PAVLASOVÁ, Gabriela and Marek MRÁZ. The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy. haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2020, vol. 105, No 6, p. 1494-1506. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2019.243543.
-
FILIP, Daniel and Marek MRÁZ. The role of MYC in the transformation and aggressiveness of ?indolent? B-cell malignancies. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2020, vol. 61, No 3, p. 510-524. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2019.1675877.
-
LOBELLO, Cosimo, Boris TICHÝ, Lenka RADOVÁ, Daniel FILIP, Marek MRÁZ, I. MOJARRO, F. FEND, N. PROKOPH, H. LAROSE, S. TURNER, HCh. LIANG, O. MERKEL, K. KAMARÁDOVÁ, D. BELADA, G. SHARMA, L. MOLOGNI, C. GAMBACORTI-PASSERINI, Andrea JANÍKOVÁ and Šárka POSPÍŠILOVÁ. Analysis of Mutational Landscape in Systemic Anaplastic Large Cell Lymphoma Identifies Novel Prognostic Markers. In 61st ASH Annual Meeting and Exposition. Orlando, Florida, USA. 2019.
-
BOUDNÝ, Miroslav, PrashantKumar KHIRSARIYA, Marek BORSKÝ, Yvona BRYCHTOVÁ, Kamil PARUCH and Martin TRBUŠEK. ATR-CHK1 signaling is active and targetable in quiescent CLL cells. In 24th European Hematology Association Cogress, Amsterdam, Nizozemsko in HemaSpehere. 2019.
-
MUSILOVÁ, Kateřina, Kateřina AMRUZ ČERNÁ, Sonali SHARMA, Václav ŠEDA, Gabriela MLADONICKÁ PAVLASOVÁ, Jan OPPELT, Daniel FILIP, Veronika ŠANDOVÁ, Laura ONDRIŠOVÁ, Šárka POSPÍŠILOVÁ, Eva VOJÁČKOVÁ, Pedro FARIA ZENI, Jiří MAYER and Marek MRÁZ. B Cell Receptor Signalling Regulation by Non-coding RNAs. In EU-LIFE Scientific Meeting 2019, Cambridge, UK. 2019.
-
MLADONICKÁ PAVLASOVÁ, Gabriela, Veronika ŠANDOVÁ, Marek BORSKÝ, Jan OPPELT, Václav ŠEDA, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. CD20 in the context of microenvironmental interactions of malignant B cells: Implications for targeted therapy. In XXV. Pařízkovy dny, Ostrava. 2019.
-
ONDROUŠKOVÁ, Eva, Michaela BOHÚNOVÁ, B. RICHTEROVÁ, P. ŠMUHAŘOVÁ, Miroslav BOUDNÝ, P. ČECH, Karla PLEVOVÁ, Kristýna ZÁVACKÁ, Jana KOTAŠKOVÁ, Martin TRBUŠEK, Šárka POSPÍŠILOVÁ and Marie JAROŠOVÁ. Cytogenetická a molekulárně biologická analýza genu a proteinu Myc u pacientů s chronickou lymfocytární leukémií. In Celostátní sjezd Společnosti lékařské genetika a genomiky ČLS JEP a 52. Výroční cytogenetická konference, Plzeň. 2019.
-
MRÁZ, Marek and Šárka POSPÍŠILOVÁ. Detection of a deletion at 22q11 locus involving ZNF280A/ZNF280B/PRAME/GGTLC2 in B-cell malignancies: simply a consequence of an immunoglobulin lambda light chain rearrangement. British journal of haematology. England: Wiley-Blackwell, 2019, vol. 186, No 4, p. "E91"-"E94", 4 pp. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.15922.
-
FEDOROVÁ, Veronika, Tereza VÁŇOVÁ, Lina Mohamed Bahaael ELREFAE, Jakub POSPÍŠIL, Martina PETRÁŠOVÁ, Veronika KOLAJOVÁ, Zuzana HUDACOVA, Jana BANIARIOVÁ, Martin BARÁK, Lucie PEŠKOVÁ, Tomáš BÁRTA, Markéta KAUCKÁ, Michael KILLINGER, Josef VEČEŘA, Ondřej BERNATÍK, Lukáš ČAJÁNEK, Hana HŘÍBKOVÁ and Dáša BOHAČIAKOVÁ. Differentiation of neural rosettes from human pluripotent stem cells in vitro is sequentially regulated on a molecular level and accomplished by the mechanism reminiscent of secondary neurulation. Stem Cell Research. Amsterdam: Elsevier Science BV, 2019, vol. 40, OCT 2019, p. 1-10. ISSN 1873-5061. Available from: https://dx.doi.org/10.1016/j.scr.2019.101563.
-
CHIODIN, G., D. DUTTON, EA. MARTINO, S. DRENNAN, I. TRACY, Laura ONDRIŠOVÁ, I. HENDERSON, A. D´AVOLA, Ch. PITSILLIDOU, Marek MRÁZ, P. JOHNSON, A. DUNCOMBE, G. PACKHAM, A. STEELE, H. PARKER, S. BONFIGLIO, L. SCARFO, LA. SUTTON, P. GHIA, MJJ. ROSE-ZERILLI, J. STREFFORD, F. STEVENSON and F. FORCONI. High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade During Ibrutinib Therapy in Patients with CLL. In 61st ASH Annual Meeting and Exposition. Orlando, Florida, USA. 2019.
-
CHIODIN, G., D. DUTTON, E. MARTINO, Laura ONDRIŠOVÁ, Ch. PITSILLIDOU, I. HENDERSON, I. TRACY, S. DRENNAN, A. D´AVOLA, Marek MRÁZ, P. JOHNSON, A. DUNCOMBE, G. PACKHAM, A. STEELE, L. SCARFO, P. GHIA, M. ROSE-ZERILLI, J. STREFFORD, F. STEVENSON and F. FORCONI. High surface tumor IgM levels associate with reduced response duration and with BTK bypass during ibrutinib therapy in CLL patients. In . International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Edinburgh, UK. 2019.
-
ŠPUNAROVÁ, Michaela, Nikola TOM, Šárka PAVLOVÁ, Marek MRÁZ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Hana SKUHROVÁ FRANCOVÁ, Anna BRZOBOHATÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience (Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: clinical practice experience). Leukemia Research. Oxford: PERGAMON-ELSEVIER SCIENCE LTD, 2019, vol. 81, JUN 2019, p. 75-81. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2019.04.015.
-
MRÁZ, Marek. Jak vlastně fungují anti CD 20 monoklonální protilátky? Víme více po 20 letech jejich používání? In Novinky v hematologii, Brno. 2019.
-
KOŠŤÁLOVÁ, Lenka, Václav ŠEDA and Marek MRÁZ. Komplexní mechanismy účinku inhibitorů „BCR signalizace“ a vzniku rezistence na tuto cílenou léčbu u chronické lymfocytární leukemie (Complex mechanisms of action of „BCR signalling“ inhibitors and development of resistance to this targeted therapy in chronic lymphocytic leukaemia). Transfúze a hematologie dnes. Mladá fronta a.s., 2019, vol. 25, No 4, p. 301-308. ISSN 1213-5763.
-
ONDRIŠOVÁ, Laura, Václav ŠEDA, Kateřina AMRUZ ČERNÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Eva VOJÁČKOVÁ, Jan OPPELT, Daniel FILIP, Veronika ŠANDOVÁ, Jiří MAYER and Marek MRÁZ. Mechanism of leukemia cell adaptation to targeted therapy in chronic lymphocytic leukemia. In XIX. Interdisciplinary meeting of young life scientists in Czech Chemical Society Symposium Series. 2019.
-
MRÁZ, Marek. MicroRNA a regulace BCR signalizace u B buněčných malignit: Biomarkery a terapeutické implikace. In XXIII. Biologické dny 2019 – moderní trendy biomedicínského výzkumu, Brno. 2019.
-
AMRUZ ČERNÁ, Kateřina, Jan OPPELT, Václav CHOCHOLA, Kateřina MUSILOVÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, Lenka RADOVÁ, M. ARIGONI, R.A. CALOGERO, V. BENES, Martin TRBUŠEK, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ and Marek MRÁZ. MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells (MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells.). Leukemia. London: Nature Publishing Group, 2019, vol. 33, No 2, p. 403-414. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0230-x.
-
MRÁZ, Marek. Nové mechanismy regulace B buněčné signalizace u leukémií a lymfomů. In 23. celostátní konference DNA diagnostiky, Brno. 2019.
-
BOUDNÝ, Miroslav, Jana ZEMANOVÁ, PrashantKumar KHIRSARIYA, Marek BORSKÝ, Jan VERNER, Jana ČERNÁ, Alexandra OLTOVÁ, Václav ŠEDA, Marek MRÁZ, Josef JAROŠ, Zuzana JAŠKOVÁ, Michaela ŠPUNAROVÁ, Yvona BRYCHTOVÁ, Karel SOUČEK, Stanislav DRÁPELA, Marie KAŠPÁRKOVÁ, Jiří MAYER, Kamil PARUCH and Martin TRBUŠEK. Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2019, vol. 104, No 12, p. 2443-2455. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2018.203430.
-
PEŠKOVÁ, Lucie, Kateřina AMRUZ ČERNÁ, Jan OPPELT, Marek MRÁZ and Tomáš BÁRTA. Oct4-mediated reprogramming induces embryonic-like microRNA expression signatures in human fibroblasts. Scientific reports. LONDON: NATURE PUBLISHING GROUP, 2019, vol. 9, OCT 31 2019, p. 1-13. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-019-52294-3.
-
BORSKÝ, Marek, Viera HRABČÁKOVÁ, J. NOVOTNÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER, Marek MRÁZ and Martin TRBUŠEK. Peripheral blood of CLL patients is repopulated with complement resistant malignant cells one day after rituximab infusion: possible implications for subsequent chemotherapy. In 10th International Conference Analytical Cytometry, Hotel Jizerka, Seč-Ústupky. 2019.
-
BOUDNÝ, Miroslav, Jana ZEMANOVÁ, PrashantKumar KHIRSARIYA, Marek BORSKÝ, Jan VERNER, Jana ČERNÁ, Václav ŠEDA, Marek MRÁZ, Alexandra OLTOVÁ, J. JAROŠ, Zuzana JAŠKOVÁ, Michaela ŠPUNAROVÁ, Yvona BRYCHTOVÁ, Jiří MAYER, Kamil PARUCH and Martin TRBUŠEK. Potenciál inhibice proteinu checkpoint kinase 1 u chronické lymfocytární leukémie s mutacemi v genu TP53. In XXXIII. Olomoucké hematologické dny, Olomouc. 2019.
-
BOUDNÝ, Miroslav, Jana ZEMANOVÁ, PrashantKumar KHIRSARIYA, Marek BORSKÝ, Jan VERNER, Jana ČERNÁ, Marek MRÁZ, Václav ŠEDA, Kamil PARUCH and Martin TRBUŠEK. Potenciál inhibice proteinu CHK1 u chronické lymfocytární leukemie s mutacemi v genu TP53. In XLIII. Brněnské onkologické dny v Klinická Onkologie, Brno. 2019.
-
MRÁZ, Marek, Kateřina AMRUZ ČERNÁ, Kateřina MUSILOVÁ and Jiří MAYER. Překvapivá role micro RNA v odpovědi na poškození DNA a regulaci BCR signalizace u CLL. In XIV. Brněnské hematologické dny, Brno. 2019.
-
MRÁZ, Marek. Regulation of B Cell Receptor signalling in B cell leukemias: novel mechanisms and therapeutic implications. In Biomania, Brno. 2019.
-
MRÁZ, Marek. The Impact of Regulatory RNA Molecules. In International Workshop on Chronic Lymphocytic Leukemia (iwCLL). Edinburgh, UK. 2019.
-
AMRUZ ČERNÁ, Kateřina, Kateřina MUSILOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Jan OPPELT, Daniel FILIP, Veronika ŠANDOVÁ, Eva VOJÁČKOVÁ, Sonali SHARMA, Pedro FARIA ZENI, Jiří MAYER and Marek MRÁZ. The surprising role of microRNAs in the DNA damage and B cell receptor signalling in malignant B cells. In XXXIII. Olomoucké hematologické dny, Olomouc. 2019.
-
TRACHTOVÁ, Karolína, Jan OPPELT, Kateřina AMRUZ ČERNÁ and Marek MRÁZ. Bioinformatic analysis of microRNAs and long non-coding RNAs in malignant B cells. In RNA and Disease, Uppsala, Sweden. 2018.
-
PAVLASOVÁ, Gabriela, Veronika SVOBODOVÁ, Marek BORSKÝ, Jan OPPELT, J. NOVOTNÁ, Kateřina AMRUZ ČERNÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Marek MRÁZ. CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia. 2018.
-
MRÁZ, Marek, Gabriela PAVLASOVÁ, Veronika SVOBODOVÁ, Marek BORSKÝ, Jan OPPELT, Kateřina AMRUZ ČERNÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ and Jiří MAYER. CD20 reguluje signalizaci přes B-buněčný receptor v mikroprostředí chronické lymfocytární leukémie (CD20 regulates signaling via the B-cell receptor in the microenvironment of chronic lymphocytic leukemia). In I. Český hematologický a transfuziologický sjezd, Praha. 2018.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Veronika SVOBODOVÁ, Jan OPPELT, Kateřina AMRUZ ČERNÁ, Jitka NOVOTNÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Eva VOJÁČKOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Marek MRÁZ. CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo. In AACR Annual Meeting Chicago Illinois USA. 2018.
-
ŠPUNAROVÁ, Michaela, Jitka MALČÍKOVÁ, Nikola TOM, Marek BORSKÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Hana SKUHROVÁ FRANCOVÁ, Kristina ĎURECHOVÁ, A. BRZOBOHATÁ, Anna FREIBERGEROVÁ, Marie JAROŠOVÁ, Marek MRÁZ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience. In 23rd Congress of the European Hematology Association, Stockholm, Sweden in HemaSphere. 2018.
-
ŠPUNAROVÁ, Michaela, Šárka PAVLOVÁ, Nikola TOM, Marek BORSKÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Hana SKUHROVÁ FRANCOVÁ, Andrea BRZOBOHATÁ, Anna FREIBERGEROVÁ, Marek MRÁZ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Genetické aberace a doba do progrese onemocnění u pacientů s CLL léčených režimy FCR nebo BR v 1. linii (Genetic aberrations and time to disease progression in CLL patients treated with FCR or BR regimens in 1st line). In I. Český hematologický a transfuziologický sjezd, Praha. 2018.
-
VEČEŘA, Josef, Eva BÁRTOVÁ, Jana KREJČÍ, Soňa LEGARTOVÁ, Denisa KOMŮRKOVÁ, Jana RUDÁ, Tibor ŠTARK, Eva DRAŽANOVÁ, Tomáš KAŠPÁREK, Alexandra ŠULCOVÁ, Frank J. DEKKER, Wiktor SZYMANSKI, Christian SEISER, Georg WEITZER, Raphael MECHOULAM, Vincenzo MICALE and Stanislav KOZUBEK. HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals. Journal of cellular physiology. United States: Wiley-Liss, 2018, vol. 233, No 1, p. 530-548. ISSN 0021-9541. Available from: https://dx.doi.org/10.1002/jcp.25914.
-
BOUDNÝ, Miroslav, Jana ZEMANOVÁ, PrashantKumar KHIRSARIYA, Marek BORSKÝ, Jan VERNER, Kateřina AMRUZ ČERNÁ, Marek MRÁZ, Alexandra OLTOVÁ, Zuzana JAŠKOVÁ, Michaela ŠPUNAROVÁ, Václav ŠEDA, Yvona BRYCHTOVÁ, Jiří MAYER, Kamil PARUCH and Martin TRBUŠEK. Inovativní inhibitor proteinu CHK1 indukuje apoptózu u buněk chronické lymfocytární leukémie s mutacemi v genu TP53 (An innovative CHK1 protein inhibitor induces apoptosis in chronic lymphocytic leukemia cells with mutations in the TP53 gene). In I. Český hematologický a transfuziologický sjezd, Praha. 2018.
-
MRÁZ, Marek. Microenvironmental interactions in malignant B cells: from biological mechanisms to better targeted therapies. In FN Ostrava. 2018.
-
MRÁZ, Marek. Microenvironmental interactions in malignant B cells: from biological mechanisms to better targeted therapies. In CEITEC Principal Investigator Seminar. 2018.
-
MRÁZ, Marek. Microenvironmental interactions in mature B cell malignancies: combinatorial strategies of targeted therapy. In EU-Life Paris, Francie. 2018.
-
OPPELT, Jan, Karolína TRACHTOVÁ and Marek MRÁZ. microRNA – are you real? In ENBIK2018 conference proceedings, Skalský dvůr. 2018.
-
OPPELT, Jan and Marek MRÁZ. microRNA – are you real? In RNA and Disease, Uppsala, Sweden. 2018.
-
OPPELT, Jan, Karolína TRACHTOVÁ and Marek MRÁZ. microRNA – are you real?! In ENBIK2018 - National Bioinformatics Conference. 2018. ISBN 978-80-7592-017-1.
-
MRÁZ, Marek. MicroRNAs contribute to high-grade transformation of follicular lymphoma. In Vienna Medical Center, Rakousko. 2018.
-
MUSILOVÁ, Kateřina, Ján DEVÁN, Kateřina AMRUZ ČERNÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, Sonali SHARMA, Jan OPPELT, R. PYTLIK, V. PROCHAZKA, Z. PROUZOVA, Martin TRBUŠEK, L. ZLAMALIKOVA, K. LISKOVA, L. KRUZOVA, M. JAROSOVA, Andrea MAREČKOVÁ, C. KORNAUTH, I. SIMONITSCH-KLUPP, A.I. SCHIEFER, O. MERKEL, H. MOCIKOVA, P. BURDA, K.M. POLAKOVA, L. KREN, Jiří MAYER, C.S. ZENT, M. TRNENY, A.G. EVANS, Andrea JANÍKOVÁ and Marek MRÁZ. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels. Blood. Washington DC, USA: American Society of Hematology, 2018, vol. 132, No 22, p. 2389-2400. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2018-06-855502.
-
MUSILOVÁ, Kateřina, Ján DEVÁN, Kateřina AMRUZ ČERNÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, R. PYTLÍK, V. PROCHÁZKA, Zuzana PROUZOVÁ, Martin TRBUŠEK, Lenka ZLÁMALÍKOVÁ, Květoslava LIŠKOVÁ, L. KRŮZOVÁ, Marie JAROŠOVÁ, C. KORNAUTH, I. SIMONITSCH-KLUPP, AI. SCHIEFER, O. MERKEL, P. BURDA, Kateřina MACHOVÁ POLÁKOVÁ, Heidi MÓCIKOVÁ, Leoš KŘEN, Jiří MAYER, Marek TRNĚNÝ, CS. ZENT, A. EVANS, Andrea JANÍKOVÁ and Marek MRÁZ. MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels. In 23rd Congress of the European Hematology Association, Stockholm, Sweden. 2018.
-
MRÁZ, Marek, Kateřina MUSILOVÁ, Ján DEVÁN, Kateřina AMRUZ ČERNÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, R. PYTLÍK, V. PROCHÁZKA, Zuzana PROUZOVÁ, Lenka ZLÁMALÍKOVÁ, Květoslava LIŠKOVÁ, L. KRUZOVA, P. BURDA, Kateřina MACHOVÁ POLÁKOVÁ, Heidi MÓCIKOVÁ, Leoš KŘEN, Jiří MAYER, Marek TRNĚNÝ and Andrea JANÍKOVÁ. MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma to DLBCL by upregulating FOXP1 levels. In XXXII. Olomoucké hematologické dny. 2018.
-
DEVÁN, Ján, Andrea JANÍKOVÁ and Marek MRÁZ. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs. SEMINARS IN ONCOLOGY. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC, 2018, vol. 45, 5-6, p. 291-302. ISSN 0093-7754. Available from: https://dx.doi.org/10.1053/j.seminoncol.2018.07.005.
-
MRÁZ, Marek. Překvapivé mechanismy regulace signalizace B buněčného receptoru (BCR): od mechanismů k terapii B buněčných malignit. In BioMed Martin, Slovensko. 2018.
-
AMRUZ ČERNÁ, Kateřina and Marek MRÁZ. p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and FOXP1. Oncotarget. 2018, vol. 9, No 92, p. 36409-36410. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.26376.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Veronika ŠANDOVÁ, Jan OPPELT, Kateřina AMRUZ ČERNÁ, Jitka NOVOTNÁ, Václav ŠEDA, Miloslava FOJTOVÁ, Jiří FAJKUS, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Marek MRÁZ. Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels. Leukemia. London: Nature Publishing Group, 2018, vol. 32, No 9, p. 2028-2031. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0211-0.
-
BOUDNÝ, Miroslav, Jana ZEMANOVÁ, PrashantKumar KHIRSARIYA, Marek BORSKÝ, Jan VERNER, Jana ČERNÁ, Marek MRÁZ, Alexandra OLTOVÁ, Zuzana JAŠKOVÁ, Michaela ŠPUNAROVÁ, Václav ŠEDA, Yvona BRYCHTOVÁ, Jiří MAYER, Kamil PARUCH and Martin TRBUŠEK. Selective CHK1 inhibitor MU380 exhibits single-agent activity against chronic lymphocytic leukemia cells with TP53 mutations. In 23rd Congress of the European Hematology Association, Stockholm, Sweden in HemaSphere. 2018.
-
DEVÁN, Ján, Kateřina MUSILOVÁ and Marek MRÁZ. The expression of T-cell specific microRNA associates with the transformation of indolent follicular lymphoma to agressive lymphomas. In CEITEC PHD and POSTDOC RETREAT. 2018.
-
STAMATOPOULOS, B., T. SMITH, E. CROMPOT, K. PIETERS, R. CLIFFORD, Marek MRÁZ, P. ROBBE, A. BURNS, A. TIMBS, D. BRUCE, P. HILLMEN, N. MEULEMAN, P. MINEUR, R. FIRESCU, M. MAEREVOET, V. DE WILDE, A. EFIRA, J. PHILIPPE, B. VERHASSELT, F. OFFNER, D. SIMS, A. HEGER, H. DREAU and A. SCHUH. The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study. Clinical cancer research. Philadelphia: AMER ASSOC CANCER RESEARCH, 2018, vol. 24, No 20, p. 5048-5057. ISSN 1078-0432. Available from: https://dx.doi.org/10.1158/1078-0432.CCR-18-0133.
-
MRÁZ, Marek. The surprises in B cell receptor signalling regulation: from basic biology to therapeutic implications in B cell malignancies. In Southampton University, Spojené Království. 2018.
-
MRÁZ, Marek. Transformace folikulárního lymfomu. In X. Plenární zasedání ČS CLL, Praha. 2018.
-
BOUDNÝ, Miroslav, Alexandra OLTOVÁ, Kamil PARUCH and Martin TRBUŠEK. ATR-Chk1 pathway as a therapeutic target for leukemia and lymphoma. In CEITEC PHD RETREAT II 2017, Telč. 2017.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Veronika SVOBODOVÁ, Kateřina MUSILOVÁ, Kateřina ČERNÁ, Václav ŠEDA, Jitka NOVOTNÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Marek MRÁZ. BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo. In 22nd EHA Annual Congress; Madrid, Spain, červen 2017 in Haematologica 2017. 2017.
-
DEVÁN, Ján and Marek MRÁZ. Buněčná biologie folikulárního lymfomu (The molecular biology of follicular lymphoma). In Vít Procházka. Folikulární lymfom. První vyd. Praha: Mladá fronta, 2017, p. 54-74. Edice postgraduální medicíny. ISBN 978-80-204-4120-1.
-
BALOUN, Jiří, Petra BENCÚROVÁ, Kateřina MUSILOVÁ, Martin PAIL, Eva BRICHTOVÁ, Markéta HERMANOVÁ, Hana KUBOVÁ, Marek MRÁZ, Milan BRÁZDIL and Šárka POSPÍŠILOVÁ. Comparative analysis of miRNA profiles in human patients with epilepsy and animal model. In Non-coding RNAs in Nervous System Development, Plasticity and Disease. 2017.
-
BALOUN, Jiří, Petra BENCÚROVÁ, Kateřina MUSILOVÁ, Martin PAIL, Eva BRICHTOVÁ, Markéta HERMANOVÁ, Hana KUBOVÁ, Marek MRÁZ, Milan BRÁZDIL and Šárka POSPÍŠILOVÁ. Comparative analysis of miRNA profiles in human patients with epilepsy and animal models. 2017.
-
MUSILOVÁ, Kateřina, Gabriela PAVLASOVÁ, Václav ŠEDA, Eva VOJÁČKOVÁ, Kateřina ČERNÁ, Veronika SVOBODOVÁ, Robert PYTLÍK, Vít PROCHÁZKA, Zuzana PROUZOVÁ, Šárka POSPÍŠILOVÁ, Lenka ZLÁMALÍKOVÁ, Heidi MÓCIKOVÁ, Lenka KRUZOVÁ, Marie JAROŠOVÁ, A. EVANS, C. ZENT, Leoš KŘEN, Marek TRNĚNÝ, Jiří MAYER, Andrea JANÍKOVÁ and Marek MRÁZ. Differential expression of microRNAs in transformation of follicular lymphoma to diffuse large B cell lymphoma. In 107th AACR Annual Meeting, Washington, D.C., USA, duben 2017 in Cancer Research 2017. 2017.
-
HLOŽKOVÁ, Michaela, Jitka MALČÍKOVÁ, Nikola TOM, Marek BORSKÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Eva DIVÍŠKOVÁ, Marek MRÁZ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Dopad rekurentních mutací na dobu do progrese po terapiích zahrnujících rituximab v 1. linii u pacientů s CLL. (Impact of recurrent mutations over time to progression following rituximab first line therapy in patients with CLL). In XXXI. Olomoucké hematologické dny. 2017.
-
MUSILOVÁ, Kateřina, Gabriela PAVLASOVÁ, Václav ŠEDA, Kateřina ČERNÁ, Eva VOJÁČKOVÁ, Jana DIDI, R. PYTLÍK, V. PROCHÁZKA, Zuzana PROUZOVÁ, Lenka ZLÁMALÍKOVÁ, Heidi MÓCIKOVÁ, Marie JAROŠOVÁ, A. EVANS, C. ZENT, Leoš KŘEN, Marek TRNĚNÝ, Jiří MAYER, Andrea JANÍKOVÁ and Marek MRÁZ. Down-regulation of miR-150 and up-regulation of its target FOXP1 is associated with transformation of follicular lymphoma. In 14th International Conference on Malignant Lymphoma (14-ICML), Lugano, Switzerland, červen 2017 in Hematological Oncology 2017. 2017.
-
JAROŠOVÁ, Marie, M. HRUBA, Alexandra OLTOVÁ, Karla PLEVOVÁ, L. KRUZOVA, E. KRIEGOVA, R. FILLEROVA, Eva KORIŤÁKOVÁ, Michael DOUBEK, D. LYSAK, V. PROCHAZKA, Marek MRÁZ, K. INDRAK and T. PAPAJIK. Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients. American Journal of Hematology. NJ 07030-577 United States: John Wiley & Sons, 2017, vol. 92, No 10, p. "E604"-"E607", 5 pp. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.24852.
-
ŠPUNAROVÁ, Michaela, Jitka MALČÍKOVÁ, Nikola TOM, Marek BORSKÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Eva DIVÍŠKOVÁ, Marek MRÁZ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens. In 22nd congress of EHA, Madrid, Španělsko, červen 2017 in Haematologica (2017). 2017.
-
BENCÚROVÁ, Petra, Jiří BALOUN, Kateřina MUSILOVÁ, Lenka RADOVÁ, Boris TICHÝ, Martin PAIL, Martin ZEMAN, Eva BRICHTOVÁ, Markéta HERMANOVÁ, Šárka POSPÍŠILOVÁ, Marek MRÁZ and Milan BRÁZDIL. MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus. Epilepsia. Blackwell Science, 2017, vol. 58, No 10, p. 1782-1793. ISSN 0013-9580. Available from: https://dx.doi.org/10.1111/epi.13870.
-
MicroRNA induced by DNA damage response regulate the expression of FOXP1 and therapy response in CLLČERNÁ, Kateřina, Jan OPPELT, Václav ŠEDA, Kateřina MUSILOVÁ, Gabriela PAVLASOVÁ, Veronika SVOBODOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ and Marek MRÁZ. MicroRNA induced by DNA damage response regulate the expression of FOXP1 and therapy response in CLL. In 2nd International Conference on the Long and the Short of Non-Coding RNAs, Heraklion, Greece. 2017.
-
ČERNÁ, Kateřina, Jan OPPELT, Václav ŠEDA, Kateřina MUSILOVÁ, Gabriela PAVLASOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ and Marek MRÁZ. MicroRNA induced by DNA damage response regulates the expression of FOXP1 and therapy response in CLL. In XVII International Workshop on Chronic Lymphocytic Leukemia, USA, New York. 2017.
-
MRÁZ, Marek. MicroRNAs and BCR signalling in CLL. In UK CLL Forum Annual Scientific Day, Londýn. 2017.
-
BENCÚROVÁ, Petra, Jiří BALOUN, Kateřina MUSILOVÁ, Lenka RADOVÁ, Martin PAIL, Markéta HERMANOVÁ, Šárka POSPÍŠILOVÁ, Marek MRÁZ and Milan BRÁZDIL. miRNA profile of mesial temporal lobe epilepsy. In CEITEC PhD Retreat II. 2017. ISBN 978-80-210-8550-3.
-
VEČEŘA, Josef, Jana KUDOVÁ, Jan KUČERA, Lukáš KUBALA and Jiří PACHERNÍK. Neural Differentiation Is Inhibited through HIF1 alpha/ beta-Catenin Signaling in Embryoid Bodies. Stem Cells International. London: HINDAWI LTD, 2017, Neuveden, prosinec, p. nestránkováno, 12 pp. ISSN 1687-966X. Available from: https://dx.doi.org/10.1155/2017/8715798.
-
MRÁZ, Marek. Nové poznatky o mikroprostředí a BCR signalizaci u CLL a lymfomů. Implikace pro cílenou léčbu a terapeutickou rezistenci. In Novinky v hematologii, Brno. 2017.
-
DEVÁN, Ján, Kateřina MUSILOVÁ, Andrea JANÍKOVÁ and Marek MRÁZ. Nové poznatky o patogenezi folikulárního lymfomu a koncepty cílené léčby (Novel Findings in Follicular Lymphoma Pathogenesis and the Concepts of Targeted Therapy). Klinická onkologie. Praha: Ambit Media, 2017, vol. 30, No 4, p. 247-257. ISSN 0862-495X. Available from: https://dx.doi.org/10.14735/amko2017247.
-
BOUDNÝ, Miroslav, Jana ZEMANOVÁ, Marek BORSKÝ, Michaela HLOŽKOVÁ, Jitka MALČÍKOVÁ, Eva DIVÍŠKOVÁ, Yvona BRYCHTOVÁ, Kamil PARUCH and Martin TRBUŠEK. Potenciál inhibice proteinu Chk1 u chronické lymfocytární leukémie s mutacemi v genu TP53. (90/5000 Potential for the inhibition of Chk1 protein in chronic lymphocytic leukemia with mutations in the TP53 gene). In XXXI. Olomoucké hematologické dny. 2017.
-
ŠEDA, Václav, Eva VOJÁČKOVÁ, Tomáš LOJA, Gabriela PAVLASOVÁ, Kateřina ČERNÁ, Kateřina MUSILOVÁ, Veronika SVOBODOVÁ, Sonali SHARMA and Marek MRÁZ. Regulation of B-cell receptor signalling in chronic lymphocytic leukaemia (CLL) microenvironment via modulation of GAB1 protein levels. In CEITEC PHD RETREAT II, Telč. 2017.
-
MRÁZ, Marek. The complexity of BCR signaling in CLL and other B cell malignancies: from the basic science to clinical applications. In XXXI. Olomoucké hematologické dny. 2017.
-
PAVLASOVÁ, Gabriela, Kateřina MUSILOVÁ, Václav ŠEDA, Kateřina ČERNÁ, Eva VOJÁČKOVÁ, Veronika SVOBODOVÁ and Marek MRÁZ. The identification of combinatorial therapeutic approaches with BCR inhibitors in B cell malignancies. In AACR Precision Medicine Series: Opportunities and Challenges of Exploiting Synthetic Lethality in Cancer. 2017. ISSN 1535-7163. Available from: https://dx.doi.org/10.1158/1538-8514.SYNTHLETH-A34.
-
OPPELT, Jan and Marek MRÁZ. The impact of choice of reference gene annotation. In CEITEC PhD Retreat II. 2017. ISBN 978-80-210-8550-3.
-
VOJÁČKOVÁ, Eva, Václav ŠEDA, Tomáš LOJA, Kateřina ČERNÁ, Kateřina MUSILOVÁ, Gabriela PAVLASOVÁ, Veronika SVOBODOVÁ, Sonali SHARMA and Marek MRÁZ. The role of microenvironment in the regulation of B-cell receptor signalling via modulation of GAB1 protein levels. In XVII. Mezioborové setkání mladých biologů, biochemiků a chemiků; Devět Skal Milovy, květen/červen 2017 in Czech Chemical Society Symposium Series (2017). 2017.
-
MUSILOVÁ, Kateřina, Ján DEVÁN, Lenka ZLÁMALÍKOVÁ, Leoš KŘEN, H. MÓCIKOVÁ, V. PROCHÁZKA, Jiří MAYER, Marek TRNĚNÝ, Andrea JANÍKOVÁ and Marek MRÁZ. Význam deregulace mikroRNA v molekulární patogenezi a histologické transformaci folikulárního lymfomu (The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma). Klinická onkologie. Praha: Ambit Media, 2017, vol. 30, Suppl. 1, p. 163-165. ISSN 0862-495X.
-
MUSILOVÁ, Kateřina, Ján DEVÁN, Lenka ZLÁMALÍKOVÁ, Leoš KŘEN, Hana MÔCIKOVÁ, Vladimír PROCHÁZKA, Jiří MAYER, Marek TRNĚNÝ, Andrea JANÍKOVÁ and Marek MRÁZ. Význam deregulace mikroRNA v molekulární patogenezi a histologické transformaci folikulárního lymfomu (The importance of deregulation of microRNA in molecular pathogenesis and histological transformation of follicular lymphoma). In XLI. Brněnské onkologické dny. 2017.
-
KUČERA, Jan, Lucia BINÓ, Kateřina ŠTEFKOVÁ, Josef JAROŠ, Ondřej VAŠÍČEK, Josef VEČEŘA, Lukáš KUBALA and Jiří PACHERNÍK. Apocynin and Diphenyleneiodonium Induce Oxidative Stress and Modulate PI3K/Akt and MAPK/Erk Activity in Mouse Embryonic Stem Cells. Oxidative Medicine and Cellular Longevity. Hindawi Publishing Corporation, 2016, vol. 2016, No 7409196, p. 1-14. ISSN 1942-0900. Available from: https://dx.doi.org/10.1155/2016/7409196.
-
MRÁZ, Marek. Biologické aspekty FL a transformace. In Czech Cooperative Lymphoma Group Meeting, Praha, březen 2016. 2016.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, JR. BROWN, Jiří MAYER and Marek MRÁZ. Exprese CD20 je regulována interakcí CLL buněk s mikroprostředím a rituximab preferenčně eliminuje maligní B buňky s vysoce aktivní signalizací přes B‐buněčný receptor. In 17. Pražský hematologický den. 2016.
-
SÝKOROVÁ, A., R. PYTLÍK, H. MÓCIKOVÁ, D. BELADA, K. BENEŠOVÁ, T. PAPAJÍK, Andrea JANÍKOVÁ, David ŠÁLEK, V. PROCHÁZKA, S. VOKURKA, V. CAMPR, P. KLENER, K. KUBÁČKOVÁ and M. TRNĚNÝ. Hodnocení klinického stadia a léčebné odpovědi u maligních lymfomů – doporučení Kooperativní lymfomové skupiny na základě revidovaných kritérií z roku 2014 (Luganská klasifikace) (Staging and Treatment Response Evaluation in Malignant Lymphomas – Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)). Klinická onkologie. Praha: Ambit Media, 2016, vol. 29, No 4, p. 295-302. ISSN 0862-495X. Available from: https://dx.doi.org/10.14735/amko2016295.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Václav ŠEDA, Kateřina ČERNÁ, Jitka OSIČKOVÁ, Michael DOUBEK, Jiří MAYER, R. CALOGERO, Šárka POSPÍŠILOVÁ, M. DAVIDS, J. BROWN and Marek MRÁZ. Ibrutinib inhibits CD20 up-regulation on CLL B cells mediated by the CXCR4/SDF-1 axis. In Haematologica (2016); 101(s1): 47 (21st Congress of the EHA, Dánsko). 2016.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Václav ŠEDA, Kateřina ČERNÁ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ, M. DAVIDS, J. BROWN and Marek MRÁZ. Ibrutinib inhibits CD20 up-regulation on CLL B cells mediated by the CXCR4/SDF-1 AXIS. In XXX. Olomoucké hematologické dny. 2016.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Václav ŠEDA, Kateřina ČERNÁ, Jitka OSIČKOVÁ, Michael DOUBEK, Jiří MAYER, Raffaele CALOGERO, Martin TRBUŠEK, Šárka POSPÍŠILOVÁ, Matthew S. DAVIDS, Thomas J. KIPPS, Jennifer R. BROWN and Marek MRÁZ. Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis. Blood. Washington DC, USA: American Society of Hematology, 2016, vol. 128, No 12, p. 1609-1613. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2016-04-709519.
-
BENCÚROVÁ, Petra, Jiří BALOUN, Kateřina MUSILOVÁ, Karol PÁL, Nikola TOM, Jakub HYNŠT, Lenka RADOVÁ, Martin PAIL, Eva BRICHTOVÁ, Markéta HERMANOVÁ, Šárka POSPÍŠILOVÁ, Marek MRÁZ and Milan BRÁZDIL. Identification of miRNA expression profiles in human mesial temporal lobe epilepsy with hippocampal sclerosis. In 12th European Congress on Epileptology. 2016.
-
JANÍKOVÁ, Andrea, Zbyněk BORTLÍČEK, Vit CAMPR, Natasa KOPALOVA, Katerina BENESOVA, Jitka HAMOUZOVA, David BELADA, Vit PROCHAZKA, Robert PYTLIK, Samuel VOKURKA, Jan PIRNOS, Juraj DURAS, Heidi MOCIKOVA, Jiří MAYER and Marek TRNENY. Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database. Leukemia & Lymphoma. Oxon: Taylor & Francis LTD, 2016, vol. 57, No 5, p. 1094-1103. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2015.1079313.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, J. BROWN, Šárka POSPÍŠILOVÁ and Marek MRÁZ. Interakce B lymfocytů s mikroprostředím vedou ke zvýšené expresi CD20 přes aktivaci dráhy CXCR4/SDF-1: význam pro léčbu pacientů s B buněčnou leukémií. In XVI. mezioborové setkání mladých biologů, biochemiků a chemiků (Czech Chemical Society Symposium Series (2016); 14(2): 77-78). 2016.
-
PARDY, Filip, Boris TICHÝ, Karol PÁL, Nikola TOM, Kateřina ČERNÁ, Marek MRÁZ and Kristýna HRAZDILOVÁ. Introduction of nanopore sequencing to genomic core facility RNA workflows. In London calling, Londýn, květen 2016. 2016.
-
MRÁZ, Marek, Kateřina ČERNÁ, Gabriela PAVLASOVÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Jiří MAYER and Šárka POSPÍŠILOVÁ. MicroRNAs in the microenvironmental interactions of B cell leukemias. In XXV. Biochemický sjezd, Praha. 2016.
-
JANÍKOVÁ, Andrea, Eva MIČULKOVÁ, Andrea MAREČKOVÁ, N. KOPALOVÁ, Jozef MICHALKA, David ŠÁLEK, Dana DVOŘÁKOVÁ, Leoš KŘEN, Ivo HANKE, Šárka POSPÍŠILOVÁ and Jiří MAYER. Molecular activity in follicular lymphoma monitored by BCL2/IGH in the peripheral blood. The old story in a new light? In Haematologica (2016); 101(s1): 478-461 (21st Congress of the EHA). 2016.
-
MRÁZ, Marek. Nové poznatky o patogenezi B buněčných malignit a cesty k cílené léčbě. In Novinky v hematologii, Brno. 2016.
-
OPPELT, Jan, Marie JANKŮJOVÁ and Marek MRÁZ. Porovnání výsledků genové exprese pří použití různých anotací genomu (Comparison of the results of gene expression using different genome annotation). In ENBIK2016. 2016. ISBN 978-80-7080-960-0.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Kateřina MUSILOVÁ, Václav ŠEDA, Kateřina ČERNÁ, Jitka OSIČKOVÁ, Eva VOJÁČKOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Marek MRÁZ. Rituximab preferentially eliminates BCR signaling proficient chronic lymphocytic leukemia B cells In Vivo. In Blood (2016); s. 2030. (58th ASH Annual Meeting and Exposition, San Diego, USA, prosinec 2016). 2016.
-
MOCIKOVA, Heidi, Robert PYTLIK, Alice SYKOROVA, Andrea JANÍKOVÁ, Vit PROCHAZKA, Samuel VOKURKA, Adela BERKOVA, David BELADA, Vit CAMPR, Lucie BURESOVA and Marek TRNENY. Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry. Leukemia & Lymphoma. London: Informa Healthcare, 2016, vol. 57, No 12, p. 2777-2783. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2016.1167203.
-
RADASZKIEWICZ, Katarzyna Anna, Dominika SÝKOROVÁ, Pavel KARAS, Jana KUDOVÁ, Lukáš KOHÚT, Lucia BINÓ, Josef VEČEŘA, Jan VÍTEČEK, Lukáš KUBALA and Jiří PACHERNÍK. Simple non-invasive analysis of embryonic stem cell-derived cardiomyocytes beating in vitro. Review of Scientific Instruments. Melville (USA): American Institute of Physics, 2016, vol. 87, No 2, p. "nestrankovano", 7 pp. ISSN 0034-6748. Available from: https://dx.doi.org/10.1063/1.4941776.
-
MRÁZ, Marek. The biology of microRNAs and how to move this into clincal trials in hematological malignancies. In European Hematology Association Annual Meeting 2016 (EHA), Dánsko, červen 2016. 2016.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Václav ŠEDA, Kateřina ČERNÁ, Jitka OSIČKOVÁ, Michael DOUBEK, Yvona BRYCHTOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ, M. DAVIDS, J. BROWN and Marek MRÁZ. The expression of CD20 on malignant B cells is regulated by chemokine signaling through the CXCR4/SDF1 axis: implications for targeting the microenvironmental interactions. In Cancer Research (2016); 76 (14S): 3291 (AACR Annual Meeting; New Orleans, USA). 2016.
-
TRNĚNÝ, Marek, V CAMPR, Andrea JANÍKOVÁ, D BELADA, V PROCHAZKA, Heidi MÓCIKOVÁ, Jan PIRNOS, Kristina KUBAČKOVÁ, JULIA COIDURAS HUGUET, L BARSOVA, Jana PUKYOVÁ, M BREJCHA, S VOKURKA, Dagmar ADAMOVÁ, R BARSOVA, D STAROSTKA, Martina CHODACKÁ, P KESSLER, Radek PYTLÍK, Ladislav DUŠEK, K BENESOVA, A SYKOROVA, J DLOUHA, P BLAHOVCOVA and Ludmila BOUDOVÁ. THE IMPROVING OUTCOME OF NON-HODGKIN LYMPHOMA (NHL) WITHIN 15 YEARS PERIOD-REAL WORLD DATA OF NATIONAL-WIDE LYMPHOMA PROJECT. 2016.
-
BARTOVA, Eva, Josef VEČEŘA, Jana KREJCI, Soňa LEGARTOVÁ, Jiří PACHERNÍK and Stanislav KOZUBEK. The level and distribution pattern of HP1 beta in the embryonic brain correspond to those of H3K9me1/me2 but not of H3K9me3. Histochemistry and Cell Biology. Heidelberg: Springer, 2016, vol. 145, No 4, p. 447-461. ISSN 0948-6143. Available from: https://dx.doi.org/10.1007/s00418-015-1402-7.
-
MUSILOVÁ, Kateřina, Gabriela PAVLASOVÁ, Václav ŠEDA, Eva VOJÁČKOVÁ, Kateřina ČERNÁ, Jana DIDI, Robert PYTLIK, Vít PROCHÁZKA, Zuzana PTOUZOVÁ, Lenka ZLÁMALÍKOVÁ, Šárka POSPÍŠILOVÁ, A. EVANS, C. ZENT, Leoš KŘEN, Marek TRNĚNÝ, Jiří MAYER, Andrea JANÍKOVÁ and Marek MRÁZ. The role of microRNA-150 in the prognosis and transformation of follicular lymphoma. In Blood (2016); s. 4125. (58th ASH Annual Meeting and Exposition, San Diego, USA, prosinec 2016). 2016.
-
MUSILOVÁ, Kateřina, Andrea JANÍKOVÁ and Marek MRÁZ. Úloha microRNA-150 v prognóze a transformaci folikulárního lymfomu. In Czech Chemical Society Symposium Series (2016); 14(2): 77-78 (XVI. mezioborové setkání mladých biologů, biochemiků a chemiků). 2016.
-
BENCÚROVÁ, Petra, Jiří BALOUN, Kateřina MUSILOVÁ, Šárka POSPÍŠILOVÁ, Markéta HERMANOVÁ, Lenka RADOVÁ, Martin PAIL, Eva BRICHTOVÁ, Marek MRÁZ and Milan BRÁZDIL. Whole miRNome Sequencing of Human Epileptic Brain Tissue. In 12th Annual microRNA as Biomarkers and Diagnostics. 2016.
-
MRÁZ, Marek, Kateřina ČERNÁ, Šárka POSPÍŠILOVÁ and Jiří MAYER. Způsob absolutní kvantifikace exprese miRNA, zejména miR-34a a/nebo miR-150, a jeho použití v diagnostice a prognostice B-buněčných malignit (Absolute quantification method of miRNA expression, particularly that of miR-34a and/or miR-150 and their use in diagnostics and prognostics of B-cell malignancies). 2016.
-
ŠEDA, Václav and Marek MRÁZ. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells. European Journal of Haematology. Hoboken (USA): Wiley-Blackwell, 2015, vol. 94, No 3, p. 193-205. ISSN 0902-4441. Available from: https://dx.doi.org/10.1111/ejh.12427.
-
MALČÍKOVÁ, Jitka, Kateřina STAŇO KOZUBÍK, Boris TICHÝ, Barbara KANTOROVÁ, Šárka PAVLOVÁ, Nikola TOM, Lenka RADOVÁ, Jana ŠMARDOVÁ, Filip PARDY, Michael DOUBEK, Yvona BRYCHTOVÁ, Marek MRÁZ, Karla PLEVOVÁ, Eva DIVÍŠKOVÁ, Alexandra OLTOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ and Martin TRBUŠEK. Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia. Leukemia. London: NATURE PUBLISHING GROUP, 2015, vol. 29, No 4, p. 877-885. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/leu.2014.297.
-
NERADIL, Jakub, Gabriela PAVLASOVÁ, Martin ŠRÁMEK, Michal KÝR, Renata VESELSKÁ and Jaroslav ŠTĚRBA. DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines. Oncology Reports. Athens: Spandidos Publications Ltd, 2015, vol. 33, No 5, p. 2169-2175. ISSN 1021-335X. Available from: https://dx.doi.org/10.3892/or.2015.3819.
-
JEŽ, Michal, Gabriela PAVLASOVÁ, Veronika KRMESKÁ, Kateřina ČERNÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Marek BORSKÝ, Jiří MAYER, Šárka POSPÍŠILOVÁ and Marek MRÁZ. Focal adhesion kinase regulation and expression in malignant B cells. In CEITEC PHD Retreat. 2015.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Václav ŠEDA, Kateřina ČERNÁ, Jitka OSIČKOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ, M. DAVIDS, JR. BROWN and Marek MRÁZ. Interakce buněk CLL s mikroprostředím vede ke zvýšené expresi CD20 přes chemokinovou dráhu CXCR4/SDF-1: Implikace pro léčbu anti-CD20 protilátkami a BCR-inhibitory. In XVII. Slovensko-český hematologický a transfuziologický zjazd. 2015.
-
PAVLASOVÁ, Gabriela, Václav ŠEDA, Marek BORSKÝ, Kateřina ČERNÁ, Jitka OSIČKOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ, M. DAVIDS, J. BROWN and Marek MRÁZ. Microenvironmental interactions up-regulate CD20 expression in CLL B cells through the CXCR4/SDF-1 axis: implications for CD20-targeting antibodies and the use of BCR-inhibitors in combination. In ASH in Blood,. 2015.
-
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Václav ŠEDA, Kateřina ČERNÁ, Jitka OSIČKOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ, M. DAVIDS, J. BROWN and MRÁZ. Microenvironmental interactions up-regulate CD20 expressionin CLL B cells, but confer resistance to rituximab. In XVI. International Workshop on Chronic Lymphocytic Leukemia, Sydney, Austrálie. 2015.
-
ČERNÁ, Kateřina, Jan OPPELT, Lenka RADOVÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, Michal JEŽ, Nikola TOM, Filip PARDY, Jitka MALČÍKOVÁ, Karla PLEVOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Martin TRBUŠEK, Jiří MAYER, Jaroslav KOČA, R. CALOGERO, Šárka POSPÍŠILOVÁ and Marek MRÁZ. MicroRNA involvement in DNA damage response and BCR signaling in malignant B cells. In AACR Annual Meeting 2015. 2015.
-
MUSILOVÁ, Kateřina and Marek MRÁZ. MicroRNAs in B cell lymphomas: how a complex biology gets more complex. Leukemia. London: Nature Publishing Group, 2015, vol. 29, No 5, p. 1004-1017. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/leu.2014.351.
-
ČERNÁ, Kateřina, Jan OPPELT, Lenka RADOVÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, Michal JEŽ, Nikola TOM, Jitka MALČÍKOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Martin TRBUŠEK, Jiří MAYER, Jaroslav KOČA, M. ARIGONI, F. RICARDO, R. CALOGERO, Šárka POSPÍŠILOVÁ and Marek MRÁZ. MicroRNAs in DNA damage response and BCR signaling in malignant B cells. In MicroRNAs and Noncoding RNAs in Cancer. 2015.
-
DOLEŽALOVÁ, Dáša, Marek MRÁZ and Aleš HAMPL. MicroRNAs in Embryonic Stem Cells. In Chandan K. Sen. MicroRNA in regenerative medicine. London: Elsevier, 2015, p. 183-212. ISBN 978-0-12-405544-5. Available from: https://dx.doi.org/10.1016/B978-0-12-405544-5.00007-1.
-
MUSILOVÁ, Kateřina, Gabriela PAVLASOVÁ, Jana DIDI, Václav ŠEDA, Kateřina ČERNÁ, Michal JEŽ, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER, M. ARIGONI, F. RICCARDO, R. CALOGERO, Šárka POSPÍŠILOVÁ, T. KIPPS, JANÍKOVÁ and MRÁZ. MicroRNA-150 influences microenvironmental interactions and prognosis of B cell malignancies. In XXX. Olomoucké hematologické dny s mezinárodní účastí. 2015.
-
MUSILOVÁ, Kateřina, Gabriela PAVLASOVÁ, Jana DIDI, Václav ŠEDA, Kateřina ČERNÁ, Michal JEŽ, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER, M. ARIGONI, F. RICCARDO, R. CALOGERO, Šárka POSPÍŠILOVÁ, T. KIPPS, A JANÍKOVÁ and Marek MRÁZ. MicroRNA-150 influences microenvironmental interactions and prognosis of B cell malignancies. In ESH 2015. 2015.
-
MUSILOVÁ, Kateřina, Gabriela PAVLASOVÁ, Kateřina ČERNÁ, Václav ŠEDA, Michal JEŽ, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER, M. ARIGONI, F. RICCARDO, R. CALOGERO, Šárka POSPÍŠILOVÁ, T. KIPPS, Andrea JANÍKOVÁ and Marek MRÁZ. MicroRNA-150 influences microenvironmental interactions and prognosis of follicular lymphoma. In 13th International Conference on Malignant Lymphoma in Hematological Oncology. 2015.
-
OPPELT, Jan, Jaroslav KOČA and Marek MRÁZ. miRNome-wide regulation of microRNA expression. In Algorithmics, Bioinformatics and Statistics for NGS data analysis. 2015.
-
TOM, Nikola, Jitka MALČÍKOVÁ, Lenka RADOVÁ, Barbara KANTOROVÁ, Filip PARDY, Šárka PAVLOVÁ, Karol PÁL, Marek MRÁZ, Boris TICHÝ, Michael DOUBEK, Yvona BRYCHTOVÁ, Karla PLEVOVÁ, Jiří MAYER, Martin TRBUŠEK and Šárka POSPÍŠILOVÁ. Mutations in the TP53 gene show features of somatic hypermutation process with prominent difference between IGHV mutated and unmutated chronic lymphocytic leukemia. In 20th Congress of the European Hematology Association in Haematologica. 2015.
-
DOUBEK, Michael, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Ludmila ŠEBEJOVÁ, Olga STEHLÍKOVÁ, Jana CHOVANCOVÁ, Jitka MALČÍKOVÁ, Jana ŠMARDOVÁ, Karla PLEVOVÁ, Pavlína VOLFOVÁ, Martin TRBUŠEK, Marek MRÁZ, Denisa BAKEŠOVÁ, Jakub TRIZULJAK, Markéta HADRABOVÁ, Petra OBRTLÍKOVÁ, Josef KARBAN, Lukáš SMOLEJ, Alexandra OLTOVÁ, Eva JELÍNKOVÁ, Šárka POSPÍŠILOVÁ and Jiří MAYER. Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study. American Journal of Hematology. Hoboken: Wiley-Blackwell, 2015, vol. 90, No 5, p. 417-421. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.23964.
-
KATER, A. and Marek MRÁZ. p53 function tests in relation to TP53 gene aberrations. In 1st ERIC Workshop on TP53 Analysis in CLL. 2015.
-
OPPELT, Jan, Jaroslav KOČA and Marek MRÁZ. Regulation of microRNA expression based on their common factors and properties (Regulace exprese microRNA zalozene na spolecnych faktorech a vlastnostech). In CEITEC PhD retreat. 2015. ISBN 978-80-210-7825-3.
-
OPPELT, Jan, Jaroslav KOČA and Marek MRÁZ. Regulation of microRNA expression based on their common factors and properties. In CEITEC PhD retreat. 2015. ISBN 978-80-210-7825-3.
-
ŠEDA, Václav, Michal JEŽ, Gabriela PAVLASOVÁ, Kateřina ČERNÁ, Kateřina MUSILOVÁ, Šárka POSPÍŠILOVÁ, Michael DOUBEK, Yvona BRYCHTOVÁ, Jiří MAYER and Marek MRÁZ. The effect of ZAP-70 on adaptor molecule involved in microenvironmental interactions of malignant B cells. In CEITEC PHD Retreat. 2015.
-
DOLEŽALOVÁ, Dáša, Marek MRÁZ, Ondřej URBANOVSKÝ, Josef JAROŠ and Aleš HAMPL. The role of microRNA and HMGB proteins in cell cycle regulation and differentiation of human embryonic stem cell-derived neural stem cells. In ISSCR 13th Annual Meeting, Stockholm, Sweden, 24.-27.6.2015. 2015.
-
DOLEŽALOVÁ, Dáša, Marek MRÁZ, Josef JAROŠ and Aleš HAMPL. The role of microRNA in cell cycle regulation and differetiation of human embryonic stem cell-derived neural stem cells. In Frontiers in material and life sciences: Creating life in 3D, Brno, 2.-4.9.2015. 2015.
-
RAA TE, Doreen G., Jitka MALČÍKOVÁ, Marek MRÁZ, Martin TRBUŠEK, M. Le GARFF-TAVERNIER, H. MERLE-BERAL, R. GREIL, O. MERKEL, Šárka POSPÍŠILOVÁ, K. LIN, A. R. PETTITT, T. STANKOVIC, A.R. OERS VAN, M.H. ELDERING, S. STILGENBAUER, T. ZENZ and A.P. KATER. Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach. British journal of haematology. England: Wiley-Blackwell, 2014, vol. 167, No 4, p. 565-569. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.13006.
-
ČERNÁ, Kateřina, Jan OPPELT, Lenka RADOVÁ, Filip PARDY, Nikola TOM, Kateřina MUSILOVÁ, Jitka MALČÍKOVÁ, Karla PLEVOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Martin TRBUŠEK, Jaroslav KOČA, Calogero RINOLDO, Jiří MAYER, Šárka POSPÍŠILOVÁ and Marek MRÁZ. Biological and clinical relevance of mirnas induced in chronic lymphocytic leukemia (CLL) cells during administration of therapy in vivo and in vitro. 2014. ISSN 0390-6078.
-
ČERNÁ, Kateřina, Jan OPPELT, Lenka RADOVÁ, Kateřina MUSILOVÁ, Nikola TOM, Filip PARDY, Jitka MALČÍKOVÁ, Karla PLEVOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Martin TRBUŠEK, Jiří MAYER and Jaroslav KOČA. Identification of microRNAs involved in DNA damage response in malignant B cells and their biological and clinical relevance. In AACR Annual Meeting, San Diego. 2014.
-
ČERNÁ, Kateřina, Jan OPPELT, Šárka POSPÍŠILOVÁ and Marek MRÁZ. Identification of microRNAs involved in DNA damage response in malignant B cells and their biological and clinical relevance. In XVI. Setkání biochemiků a molekulárních biologů. 2014.
-
ČERNÁ, Kateřina, Jan OPPELT, Lenka RADOVÁ, Nikola TOM, Kateřina MUSILOVÁ, Jitka MALČÍKOVÁ, Karla PLEVOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Martin TRBUŠEK, Jaroslav KOČA, Jiří MAYER, Šárka POSPÍŠILOVÁ and Marek MRÁZ. Identification of microRNAs involved in DNA damage response in malignant B cells and their biological and clinical relevance. In CEITEC Annual Conference "Frontiers in Material and Life Sciences. 2014.
-
KMÍNKOVÁ, Jana, Marek MRÁZ, Kristína ZÁPRAŽNÁ, Veronika NAVRKALOVÁ, Boris TICHÝ, Karla PLEVOVÁ, Jitka MALČÍKOVÁ, Kateřina ČERNÁ, Tobias RAUSCH, Vladimír BENEŠ, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER and Šárka POSPÍŠILOVÁ. Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia. Carcinogenesis. Oxford: Oxford University Press, 2014, vol. 35, No 5, p. 992-1002. ISSN 0143-3334. Available from: https://dx.doi.org/10.1093/carcin/bgt396.
-
ČERNÁ, Kateřina, Jan OPPELT, R. CALOGERO, Šárka POSPÍŠILOVÁ and Marek MRÁZ. Identifikace MicroRNAs zapojených do reakce na poškození DNA v maligních B lymfocytech a jejich biologická a klinická relevance. In XIV. Mezioborové setkání mladých biologů, biochemiků a chemiků. 2014.
-
MRÁZ, Marek and JT. KIPPS. MicroRNA miR-150 regulates B-cell receptor signaling (BCR) and disease aggressiveness in chronic lymphocytic leukemia. In XXVIII. Olomoucké hematologické dny s mezinárodní účastí. 2014.
-
CUI, B., L. CHEN, S. ZHANG, Marek MRÁZ, J.F. FECTEAU, J. YU, E.M. GHIA, L. ZHANG, L. BAO, LZ. RASSENTI, K. MESSER, GA. CALIN, CM. CROCE and TJ. KIPPS. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood. USA: W.B. Saunders, 2014, vol. 124, No 4, p. 546-554. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2014-03-559690.
-
MRÁZ, Marek, L.G. CHEN, L.Z. RASSENTI, E.M. GHIA, H.Y. LI, K. JEPSEN, E.N. SMITH, K. MESSER, K.A. FRAZER and T.J. KIPPS. miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood. WASHINGTON: American Society of Hematology, 2014, vol. 124, No 1, p. 84-95. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2013-09-527234.
-
VEČEŘA, Josef, Veronika PÁNSKÁ, Lukáš KUBALA and Jiří PACHERNÍK. Role of HIF-1α in formation and maintenance of neural stem cells using embryonic stem cell in vitro model. In Summer school: Central concepts in developmental biology and regenerative medicine. October 4-12, 2013, Bodrum, Turkey. 2013.
-
VEČEŘA, Josef, Veronika PÁNSKÁ, Lukáš KUBALA and Jiří PACHERNÍK. Role of HIF-1α in selfrenew and differentiation of neurospheres derived from embryonic stem cells. In International Conference Analytical Cytometry VII Mikulov 2013. 2013. ISBN 978-80-905449-2-5.
-
VEČEŘA, Josef, Veronika PÁNSKÁ, Lukáš KUBALA and Jiří PACHERNÍK. Role of HIF-1α in selfrenewal capacity of neural stem cells. In Dealing with hypoxia: Regulatory aspects in cells, tissues and organisms. June 8-12, 2013, Oulu, Finland. 2013.
-
MRÁZ, Marek, Kateřina ČERNÁ, Kateřina MUSILOVÁ, Jitka MALČÍKOVÁ, Karla PLEVOVÁ, Šárka PAVLOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER, Martin TRBUŠEK and Šárka POSPÍŠILOVÁ. The expression of a single microRNA -miR-34a - is a reliable marker for impairment of TP53-pathway in chronic lymphocytic leukemia. In 18th Congress of the European Hematology Association in Haematologica, the hematology journal, Stockholm, Švédsko. 2013.
-
MRÁZ, Marek, Kateřina ČERNÁ, Kateřina MUSILOVÁ, Jitka MALČÍKOVÁ, Karla PLEVOVÁ, Šárka PAVLOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER, Martin TRBUŠEK and Šárka POSPÍŠILOVÁ. The expression of micrRNA-34a is a highly reliable for impairment of p53-pathway in CLL: development of clinically applicable assay. In XV iwCLL, Cologne, Německo. 2013.
-
MRÁZ, Marek, Kateřina STAŇO KOZUBÍK, Karla PLEVOVÁ, Kateřina MUSILOVÁ, Boris TICHÝ, Marek BORSKÝ, Petr KUGLÍK, Michael DOUBEK, Yvona BRYCHTOVÁ, Jiří MAYER and Šárka POSPÍŠILOVÁ. The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus. Leukemia Research. Oxford, UK: PERGAMON-ELSEVIER SCIENCE LTD, 2013, vol. 37, No 7, p. 802-808. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2013.03.018.
-
LÁNOVÁ, Martina, Josef VEČEŘA, Jan KUČERA, Jiřina MEDALOVÁ and Jiří PACHERNÍK. The role of ABC transporters associated with multidrug resistance in stem cells. In Stem Cells and Cell therapy: From research to modern clinical application. 2013.
-
LÁNOVÁ, Martina, Josef VEČEŘA, Jan KUČERA, Jiřina MEDALOVÁ and Jiří PACHERNÍK. The role of ATP-binding transporters associated with multi-drug resistance in stem cells. In International Conference Analytical Cytometry VII Mikulov 2013. 2013. ISBN 978-80-905449-2-5.
-
MRÁZ, Marek, Kateřina ČERNÁ, Veronika MAYEROVÁ, Kateřina MUSILOVÁ, Karla PLEVOVÁ, Šárka PAVLOVÁ, Boris TICHÝ, Michael DOUBEK, Yvona BRYCHTOVÁ, Jitka MALČÍKOVÁ, Jiří MAYER, Martin TRBUŠEK and Šárka POSPÍŠILOVÁ. Microrna-34a as a marker for fludarabine resistance and impairment of p53-pathway in chronic lymphocytic leukemia. In 54th ASH Annual Meeting and Exposition, Atlanta, USA in Blood. 2012.
-
SLABÝ, Ondřej, Marek SVOBODA, Andrej BEŠŠE, Julie BIENERTOVÁ VAŠKŮ, Kateřina ČERNÁ, Dáša DOLEŽALOVÁ, Michaela DOSTÁLOVÁ MERKEROVÁ, Jiří EHRMANN, Petra FALTEJSKOVÁ, Roman HÁJEK, Jana HÁJKOVÁ, Jaroslav JURÁČEK, Zdeněk KREJČÍK, Lenka KUBICZKOVÁ, Vlastimil KULDA, Radek LAKOMÝ, Pavla LUŽNÁ, Kateřina MACHOVÁ POLÁKOVÁ, Jiří MAYER, Veronika MAYEROVÁ, Marek MRÁZ, Kateřina MUSILOVÁ, Martin PEŠTA, Alexandr POPRACH, Šárka POSPÍŠILOVÁ, Martina RÉDOVÁ, Jiří ŠÁNA, Sabina ŠEVČÍKOVÁ, Jaroslav ŠTĚRBA, Hana VOTAVOVÁ and Rostislav VYZULA. MikroRNA v onkologii (MicroRNA in Oncology). 1.vyd. Praha: Galén, 2012, 324 pp. ISBN 978-80-7262-587-1.
-
MRÁZ, Marek, Dáša DOLEŽALOVÁ, Veronika MAYEROVÁ, Kateřina ČERNÁ, Karla PLEVOVÁ, Kateřina STAŇO KOZUBÍK, Kateřina MUSILOVÁ, Boris TICHÝ, Michael DOUBEK, Yvona BRYCHTOVÁ, Martin TRBUŠEK, T. KIPPS, Jiří MAYER and Šárka POSPÍŠILOVÁ. Úloha microRNA v regulaci signalizace přes b-buněčný receptor a jejich vztah k patogenezi chronické lymfocytární leukémie (CLL). In XVI. Česko-slovenský hematologický a transfuziologický sjezd. 2012.
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Displayed: 21/8/2024 20:22